{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:11:03Z","timestamp":1790284263478,"version":"4.1.0"},"reference-count":286,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Scientific research project of Health Commission of Jiangsu","award":["M2024034"],"award-info":[{"award-number":["M2024034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute respiratory distress syndrome (ARDS) is a severe clinical condition characterized by acute hypoxemic respiratory failure (AHRF) and diffuse pulmonary inflammation, which can be triggered by diverse intrapulmonary, extrapulmonary, and host-related factors. Over recent decades, basic research and clinical trials have significantly advanced our understanding of ARDS mechanisms, and effective comprehensive critical care interventions, including lung-protective ventilation, prone positioning, and individualized fluid management, have been widely implemented. Nevertheless, ARDS continues to be associated with substantial morbidity and mortality, and its marked clinical and biological heterogeneity remains a major obstacle to effective management and therapeutic translation. This review summarizes current evidence on ARDS epidemiology, etiology, pathophysiology, diagnosis, and clinical management. We also trace the evolution of diagnostic criteria, including the latest global definition, and critically examine disease heterogeneity, recent advances in critical care strategies, emerging therapeutic approaches, barriers to clinical translation, and future research priorities. Particular emphasis is placed on integrating clinical, physiological, and multi-omics data to support biologically and clinically meaningful patient phenotyping grounded in disease mechanisms. Building on this phenotypic stratification, innovative trial designs, including predictive enrichment and adaptive platform trials, may facilitate the development of more individualized, targeted, and dynamically adjusted treatment strategies for ARDS. In summary, establishing a precision medicine framework for ARDS that integrates etiology, mechanistic insights, phenotype-based patient stratification, individualized therapeutic strategies, and long-term management will be essential to address current challenges and improve patient outcomes.<\/jats:p>","DOI":"10.1186\/s43556-026-00532-2","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:02:03Z","timestamp":1786057323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Acute Respiratory Distress Syndrome (ARDS): epidemiology, etiology, molecular mechanisms, diagnosis and therapeutic strategies"],"prefix":"10.1186","volume":"7","author":[{"given":"Defei","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1127-9364","authenticated-orcid":false,"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"1","key":"532_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1164\/rccm.202303-0558WS","volume":"209","author":"MA Matthay","year":"2024","unstructured":"Matthay MA, Arabi Y, Arroliga AC, Bernard G, Bersten AD, Brochard LJ, et al. A New Global Definition of Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2024;209(1):37\u201347. https:\/\/doi.org\/10.1164\/rccm.202303-0558WS.","journal-title":"Am J Respir Crit Care Med"},{"key":"532_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076612","volume":"387","author":"KD Wick","year":"2024","unstructured":"Wick KD, Ware LB, Matthay MA. Acute respiratory distress syndrome. BMJ. 2024;387:e076612. https:\/\/doi.org\/10.1136\/bmj-2023-076612.","journal-title":"BMJ"},{"issue":"7","key":"532_CR3","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S2213-2600(25)00115-8","volume":"13","author":"P Nasa","year":"2025","unstructured":"Nasa P, Bos LD, Estenssoro E, van Haren FMP, Neto AS, Rocco PRM, et al. Defining and subphenotyping ARDS: insights from an international Delphi expert panel. Lancet Respir Med. 2025;13(7):638\u201350. https:\/\/doi.org\/10.1016\/S2213-2600(25)00115-8.","journal-title":"Lancet Respir Med"},{"issue":"10358","key":"532_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","volume":"400","author":"LDJ Bos","year":"2022","unstructured":"Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet. 2022;400(10358):1145\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(22)01485-4.","journal-title":"Lancet"},{"issue":"15","key":"532_CR5","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/jama.2024.14796","volume":"332","author":"VM Vaughn","year":"2024","unstructured":"Vaughn VM, Dickson RP, Horowitz JK, Flanders SA. Community-Acquired Pneumonia: A Review. JAMA. 2024;332(15):1282\u201395. https:\/\/doi.org\/10.1001\/jama.2024.14796.","journal-title":"JAMA"},{"issue":"7","key":"532_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","volume":"49","author":"G Grasselli","year":"2023","unstructured":"Grasselli G, Calfee CS, Camporota L, Poole D, Amato MBP, Antonelli M, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med. 2023;49(7):727\u201359. https:\/\/doi.org\/10.1007\/s00134-023-07050-7.","journal-title":"Intensive Care Med"},{"issue":"1","key":"532_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202311-2011ST","volume":"209","author":"N Qadir","year":"2024","unstructured":"Qadir N, Sahetya S, Munshi L, Summers C, Abrams D, Beitler J, et al. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2024;209(1):24\u201336. https:\/\/doi.org\/10.1164\/rccm.202311-2011ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"532_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-08251-y","author":"IS Morris","year":"2025","unstructured":"Morris IS, Amato M, Baedorf Kassis E, Bellani G, Calfee CS, Heunks L, et al. The medical management of acute respiratory distress syndrome. Intensive Care Med. 2025. https:\/\/doi.org\/10.1007\/s00134-025-08251-y.","journal-title":"Intensive Care Med"},{"issue":"10300","key":"532_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0140-6736(21)00439-6","volume":"398","author":"NJ Meyer","year":"2021","unstructured":"Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet. 2021;398(10300):622\u201337. https:\/\/doi.org\/10.1016\/S0140-6736(21)00439-6.","journal-title":"Lancet"},{"issue":"1","key":"532_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13054-020-03455-8","volume":"25","author":"Y Sakr","year":"2021","unstructured":"Sakr Y, Francois B, Sole-Violan J, Kotfis K, Jaschinski U, Estella A, et al. Temporal changes in the epidemiology, management, and outcome from acute respiratory distress syndrome in European intensive care units: a comparison of two large cohorts. Crit Care. 2021;25(1):87. https:\/\/doi.org\/10.1186\/s13054-020-03455-8.","journal-title":"Crit Care"},{"issue":"1","key":"532_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s13054-019-2646-8","volume":"23","author":"E Gupta","year":"2019","unstructured":"Gupta E, Hossen S, Grigsby MR, Herrera P, Roldan R, Paz E, et al. Risk factors for the development of acute respiratory distress syndrome in mechanically ventilated adults in Peru: a multicenter observational study. Crit Care. 2019;23(1):398. https:\/\/doi.org\/10.1186\/s13054-019-2646-8.","journal-title":"Crit Care"},{"issue":"2","key":"532_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.chest.2023.01.039","volume":"164","author":"A Kwizera","year":"2023","unstructured":"Kwizera A, Kabatooro D, Atumanya P, Tumukunde J, Kalungi J, Mwanje AK, et al. Respiratory Support Techniques for COVID-19-Related ARDS in a Sub-Saharan African Country: A Multicenter Observational Study. Chest. 2023;164(2):369\u201380. https:\/\/doi.org\/10.1016\/j.chest.2023.01.039.","journal-title":"Chest"},{"issue":"7","key":"532_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1164\/rccm.201609-1773CP","volume":"195","author":"T Pham","year":"2017","unstructured":"Pham T, Rubenfeld GD. Fifty years of research in ARDS. The epidemiology of acute respiratory distress syndrome. A 50th birthday review. Am J Respir Crit Care Med. 2017;195(7):860\u201370. https:\/\/doi.org\/10.1164\/rccm.201609-1773CP.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"532_CR14","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016;315(8):788\u2013800. https:\/\/doi.org\/10.1001\/jama.2016.0291.","journal-title":"JAMA"},{"issue":"23","key":"532_CR15","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","volume":"307","author":"ADT Force","year":"2012","unstructured":"Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526\u201333. https:\/\/doi.org\/10.1001\/jama.2012.5669.","journal-title":"JAMA"},{"issue":"1","key":"532_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s13054-020-03112-0","volume":"24","author":"X Huang","year":"2020","unstructured":"Huang X, Zhang R, Fan G, Wu D, Lu H, Wang D, et al. Incidence and outcomes of acute respiratory distress syndrome in intensive care units of mainland China: a multicentre prospective longitudinal study. Crit Care. 2020;24(1):515. https:\/\/doi.org\/10.1186\/s13054-020-03112-0.","journal-title":"Crit Care"},{"issue":"2","key":"532_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S2213-2600(22)00483-0","volume":"11","author":"MCJ Kneyber","year":"2023","unstructured":"Kneyber MCJ, Khemani RG, Bhalla A, Blokpoel RGT, Cruces P, Dahmer MK, et al. Understanding clinical and biological heterogeneity to advance precision medicine in paediatric acute respiratory distress syndrome. Lancet Respir Med. 2023;11(2):197\u2013212. https:\/\/doi.org\/10.1016\/S2213-2600(22)00483-0.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"532_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S2213-2600(18)30344-8","volume":"7","author":"RG Khemani","year":"2019","unstructured":"Khemani RG, Smith L, Lopez-Fernandez YM, Kwok J, Morzov R, Klein MJ, et al. Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study. Lancet Respir Med. 2019;7(2):115\u201328. https:\/\/doi.org\/10.1016\/S2213-2600(18)30344-8.","journal-title":"Lancet Respir Med"},{"key":"532_CR19","doi-asserted-by":"publisher","unstructured":"Chen L, Li J, Shi Y, Chinese Neonatal Asg. Clinical characteristics and outcomes in neonates with perinatal acute respiratory distress syndrome in China: A national, multicentre, cross-sectional study. EClin Med. 2023;55:101739. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101739.","DOI":"10.1016\/j.eclinm.2022.101739"},{"issue":"7","key":"532_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1164\/rccm.202310-1926OC","volume":"209","author":"BM Patel","year":"2024","unstructured":"Patel BM, Reilly JP, Bhalla AK, Smith LS, Khemani RG, Jones TK, et al. Association between Age and Mortality in Pediatric and Adult Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2024;209(7):871\u20138. https:\/\/doi.org\/10.1164\/rccm.202310-1926OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"532_CR21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00609-2019","author":"BA McNicholas","year":"2019","unstructured":"McNicholas BA, Madotto F, Pham T, Rezoagli E, Masterson CH, Horie S, et al. Demographics, management and outcome of females and males with acute respiratory distress syndrome in the LUNG SAFE prospective cohort study. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.00609-2019.","journal-title":"Eur Respir J"},{"issue":"1","key":"532_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-025-02127-9","volume":"10","author":"W Ma","year":"2025","unstructured":"Ma W, Tang S, Yao P, Zhou T, Niu Q, Liu P, et al. Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies. Signal Transduct Target Ther. 2025;10(1):75. https:\/\/doi.org\/10.1038\/s41392-025-02127-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"532_CR23","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S2213-2600(22)00058-3","volume":"10","author":"KD Wick","year":"2022","unstructured":"Wick KD, Matthay MA, Ware LB. Pulse oximetry for the diagnosis and management of acute respiratory distress syndrome. Lancet Respir Med. 2022;10(11):1086\u201398. https:\/\/doi.org\/10.1016\/S2213-2600(22)00058-3.","journal-title":"Lancet Respir Med"},{"issue":"12","key":"532_CR24","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00134-023-07238-x","volume":"49","author":"E Papoutsi","year":"2023","unstructured":"Papoutsi E, Kremmydas P, Tsolaki V, Kyriakoudi A, Routsi C, Kotanidou A, et al. Racial and ethnic minority participants in clinical trials of acute respiratory distress syndrome. Intensive Care Med. 2023;49(12):1479\u201388. https:\/\/doi.org\/10.1007\/s00134-023-07238-x.","journal-title":"Intensive Care Med"},{"issue":"4","key":"532_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.6370","volume":"5","author":"M Sangaramoorthy","year":"2022","unstructured":"Sangaramoorthy M, Shariff-Marco S, Conroy SM, Yang J, Inamdar PP, Wu AH, et al. Joint Associations of Race, Ethnicity, and Socioeconomic Status With Mortality in the Multiethnic Cohort Study. JAMA Netw Open. 2022;5(4):e226370. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.6370.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"532_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.202109-2163OC","volume":"205","author":"VM Ranieri","year":"2022","unstructured":"Ranieri VM, Tonetti T, Navalesi P, Nava S, Antonelli M, Pesenti A, et al. High-Flow Nasal Oxygen for Severe Hypoxemia: Oxygenation Response and Outcome in Patients with COVID-19. Am J Respir Crit Care Med. 2022;205(4):431\u20139. https:\/\/doi.org\/10.1164\/rccm.202109-2163OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"532_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00134-024-07712-0","volume":"51","author":"G Catozzi","year":"2025","unstructured":"Catozzi G, Pozzi T, Nocera D, Donati B, Giovanazzi S, Ghidoni V, et al. Rethinking ARDS classification: oxygenation impairment fails to predict VILI risk. Intensive Care Med. 2025;51(1):62\u201371. https:\/\/doi.org\/10.1007\/s00134-024-07712-0.","journal-title":"Intensive Care Med"},{"issue":"3","key":"532_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1165\/rcmb.2022-0089WS","volume":"67","author":"TR Martin","year":"2022","unstructured":"Martin TR, Zemans RL, Ware LB, Schmidt EP, Riches DWH, Bastarache L, et al. New Insights into Clinical and Mechanistic Heterogeneity of the Acute Respiratory Distress Syndrome: Summary of the Aspen Lung Conference 2021. Am J Respir Cell Mol Biol. 2022;67(3):284\u2013308. https:\/\/doi.org\/10.1165\/rcmb.2022-0089WS.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"532_CR29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1164\/rccm.202008-3265OC","volume":"203","author":"DA Dorward","year":"2021","unstructured":"Dorward DA, Russell CD, Um IH, Elshani M, Armstrong SD, Penrice-Randal R, et al. Tissue-Specific Immunopathology in Fatal COVID-19. Am J Respir Crit Care Med. 2021;203(2):192\u2013201. https:\/\/doi.org\/10.1164\/rccm.202008-3265OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"532_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.123.066433","volume":"150","author":"J Grune","year":"2024","unstructured":"Grune J, Bajpai G, Ocak PT, Kaufmann E, Mentkowski K, Pabel S, et al. Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart. Circulation. 2024;150(1):49\u201361. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066433.","journal-title":"Circulation"},{"issue":"6","key":"532_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11912-020-00920-z","volume":"22","author":"JE Reuss","year":"2020","unstructured":"Reuss JE, Suresh K, Naidoo J. Checkpoint Inhibitor Pneumonitis: Mechanisms, Characteristics, Management Strategies, and Beyond. Curr Oncol Rep. 2020;22(6):56. https:\/\/doi.org\/10.1007\/s11912-020-00920-z.","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"532_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S2213-2600(24)00417-X","volume":"13","author":"Y Shi","year":"2025","unstructured":"Shi Y, Guo Y, Li X, Wu L, Chen Z, Yang S, et al. Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study. Lancet Respir Med. 2025;13(4):327\u201337. https:\/\/doi.org\/10.1016\/S2213-2600(24)00417-X.","journal-title":"Lancet Respir Med"},{"issue":"22","key":"532_CR33","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1056\/NEJMra1208707","volume":"369","author":"AS Slutsky","year":"2013","unstructured":"Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369(22):2126\u201336. https:\/\/doi.org\/10.1056\/NEJMra1208707.","journal-title":"N Engl J Med"},{"issue":"5","key":"532_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41423-024-01146-w","volume":"21","author":"C Xu","year":"2024","unstructured":"Xu C, Zhang L, Xu S, Wang Z, Han Q, Lv Y, et al. Neutrophil ALDH2 is a new therapeutic target for the effective treatment of sepsis-induced ARDS. Cell Mol Immunol. 2024;21(5):510\u201326. https:\/\/doi.org\/10.1038\/s41423-024-01146-w.","journal-title":"Cell Mol Immunol"},{"key":"532_CR35","doi-asserted-by":"publisher","unstructured":"Xie R, Tan D, Liu B, Xiao G, Gong F, Zhang Q, et al. Acute respiratory distress syndrome (ARDS): from mechanistic insights to therapeutic strategies. MedComm (2020). 2025;6(2):e70074. https:\/\/doi.org\/10.1002\/mco2.70074.","DOI":"10.1002\/mco2.70074"},{"issue":"5","key":"532_CR36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1513\/AnnalsATS.202108-963CME","volume":"19","author":"P Toy","year":"2022","unstructured":"Toy P, Looney MR, Popovsky M, Palfi M, Berlin G, Chapman CE, et al. Transfusion-related Acute Lung Injury: 36 Years of Progress (1985\u20132021). Ann Am Thorac Soc. 2022;19(5):705\u201312. https:\/\/doi.org\/10.1513\/AnnalsATS.202108-963CME.","journal-title":"Ann Am Thorac Soc"},{"key":"532_CR37","doi-asserted-by":"publisher","unstructured":"Ghanbar MI, Suresh K. Pulmonary toxicity of immune checkpoint immunotherapy. J Clin Invest. 2024;134(2). https:\/\/doi.org\/10.1172\/JCI170503.","DOI":"10.1172\/JCI170503"},{"issue":"1","key":"532_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13054-024-04855-w","volume":"28","author":"M Ziaka","year":"2024","unstructured":"Ziaka M, Exadaktylos A. Pathophysiology of acute lung injury in patients with acute brain injury: the triple-hit hypothesis. Crit Care. 2024;28(1):71. https:\/\/doi.org\/10.1186\/s13054-024-04855-w.","journal-title":"Crit Care"},{"issue":"7899","key":"532_CR39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41586-022-04427-4","volume":"603","author":"L Hosang","year":"2022","unstructured":"Hosang L, Canals RC, van der Flier FJ, Hollensteiner J, Daniel R, Flugel A, et al. The lung microbiome regulates brain autoimmunity. Nature. 2022;603(7899):138\u201344. https:\/\/doi.org\/10.1038\/s41586-022-04427-4.","journal-title":"Nature"},{"key":"532_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","volume":"10","author":"R Enaud","year":"2020","unstructured":"Enaud R, Prevel R, Ciarlo E, Beaufils F, Wieers G, Guery B, et al. The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks. Front Cell Infect Microbiol. 2020;10:9. https:\/\/doi.org\/10.3389\/fcimb.2020.00009.","journal-title":"Front Cell Infect Microbiol"},{"key":"532_CR41","doi-asserted-by":"publisher","unstructured":"Hamanaka RB, Mutlu GM. Particulate matter air pollution: effects on the respiratory system. J Clin Invest. 2025;135(17). https:\/\/doi.org\/10.1172\/JCI194312.","DOI":"10.1172\/JCI194312"},{"issue":"8","key":"532_CR42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00134-023-07148-y","volume":"49","author":"JP Reilly","year":"2023","unstructured":"Reilly JP, Zhao Z, Shashaty MGS, Koyama T, Jones TK, Anderson BJ, et al. Exposure to ambient air pollutants and acute respiratory distress syndrome risk in sepsis. Intensive Care Med. 2023;49(8):957\u201365. https:\/\/doi.org\/10.1007\/s00134-023-07148-y.","journal-title":"Intensive Care Med"},{"key":"532_CR43","doi-asserted-by":"publisher","unstructured":"Krishnasamy VP, Hallowell BD, Ko JY, Board A, Hartnett KP, Salvatore PP, et al. Update: characteristics of a nationwide outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020. MMWR Morb Mortal Wkly Rep. 2020;69(3):90\u201394. https:\/\/doi.org\/10.15585\/mmwr.mm6903e2.","DOI":"10.15585\/mmwr.mm6903e2"},{"key":"532_CR44","doi-asserted-by":"publisher","unstructured":"Bowsher R, Marczylo TH, Gooch K, Bailey A, Wright MD, Marczylo EL. Smoking and vaping alter genes related to mechanisms of SARS-CoV-2 susceptibility and severity: a systematic review and meta-analysis. Eur Respir J. 2024;64(1). https:\/\/doi.org\/10.1183\/13993003.00133-2024.","DOI":"10.1183\/13993003.00133-2024"},{"issue":"10","key":"532_CR45","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s00134-025-08113-7","volume":"51","author":"P Schellongowski","year":"2025","unstructured":"Schellongowski P, Darmon M, Eller P, Munshi L, Liebregts T, Metaxa V, et al. Acute respiratory distress syndrome in patients with cancer: the YELENNA prospective multinational observational cohort study. Intensive Care Med. 2025;51(10):1809\u201319. https:\/\/doi.org\/10.1007\/s00134-025-08113-7.","journal-title":"Intensive Care Med"},{"issue":"3","key":"532_CR46","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s13679-024-00562-3","volume":"13","author":"A Beurton","year":"2024","unstructured":"Beurton A, Kooistra EJ, De Jong A, Schiffl H, Jourdain M, Garcia B, et al. Specific and Non-specific Aspects and Future Challenges of ICU Care Among COVID-19 Patients with Obesity: A Narrative Review. Curr Obes Rep. 2024;13(3):545\u201363. https:\/\/doi.org\/10.1007\/s13679-024-00562-3.","journal-title":"Curr Obes Rep"},{"issue":"5","key":"532_CR47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/CCM.0000000000003692","volume":"47","author":"DJ Pepper","year":"2019","unstructured":"Pepper DJ, Demirkale CY, Sun J, Rhee C, Fram D, Eichacker P, et al. Does Obesity Protect Against Death in Sepsis? A Retrospective Cohort Study of 55,038 Adult Patients. Crit Care Med. 2019;47(5):643\u201350. https:\/\/doi.org\/10.1097\/CCM.0000000000003692.","journal-title":"Crit Care Med"},{"issue":"6","key":"532_CR48","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1164\/rccm.202212-2293OC","volume":"208","author":"D Rudym","year":"2023","unstructured":"Rudym D, Pham T, Rackley CR, Grasselli G, Anderson M, Baldwin MR, et al. Mortality in Patients with Obesity and Acute Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation: The Multicenter ECMObesity Study. Am J Respir Crit Care Med. 2023;208(6):685\u201394. https:\/\/doi.org\/10.1164\/rccm.202212-2293OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"532_CR49","doi-asserted-by":"publisher","first-page":"7241","DOI":"10.1038\/s41467-024-51683-1","volume":"15","author":"KP Chung","year":"2024","unstructured":"Chung KP, Cheng CN, Chen YJ, Hsu CL, Huang YL, Hsieh MS, et al. Alveolar epithelial cells mitigate neutrophilic inflammation in lung injury through regulating mitochondrial fatty acid oxidation. Nat Commun. 2024;15(1):7241. https:\/\/doi.org\/10.1038\/s41467-024-51683-1.","journal-title":"Nat Commun"},{"key":"532_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1605797","volume":"16","author":"G Jia","year":"2025","unstructured":"Jia G, Song E, Zheng Z, Qian M, Liu G. Alveolar epithelial cells in bacterial sepsis-associated acute lung injury: mechanisms and therapeutic strategies. Front Immunol. 2025;16:1605797. https:\/\/doi.org\/10.3389\/fimmu.2025.1605797.","journal-title":"Front Immunol"},{"key":"532_CR51","doi-asserted-by":"publisher","unstructured":"Rizzo AN, Haeger SM, Oshima K, Yang Y, Wallbank AM, Jin Y, et al. Alveolar epithelial glycocalyx degradation mediates surfactant dysfunction and contributes to acute respiratory distress syndrome. JCI Insight. 2022;7(2). https:\/\/doi.org\/10.1172\/jci.insight.154573.","DOI":"10.1172\/jci.insight.154573"},{"issue":"1","key":"532_CR52","doi-asserted-by":"publisher","first-page":"6380","DOI":"10.1038\/s41467-023-42140-6","volume":"14","author":"R Erickson","year":"2023","unstructured":"Erickson R, Huang C, Allen C, Ireland J, Roth G, Zou Z, et al. SARS-CoV-2 infection of human lung epithelial cells induces TMPRSS-mediated acute fibrin deposition. Nat Commun. 2023;14(1):6380. https:\/\/doi.org\/10.1038\/s41467-023-42140-6.","journal-title":"Nat Commun"},{"issue":"7511","key":"532_CR53","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/s0140-6736(67)90168-7","volume":"2","author":"DG Ashbaugh","year":"1967","unstructured":"Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2(7511):319\u201323. https:\/\/doi.org\/10.1016\/s0140-6736(67)90168-7.","journal-title":"Lancet"},{"key":"532_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102746","volume":"63","author":"N Li","year":"2023","unstructured":"Li N, Liu B, Xiong R, Li G, Wang B, Geng Q. HDAC3 deficiency protects against acute lung injury by maintaining epithelial barrier integrity through preserving mitochondrial quality control. Redox Biol. 2023;63:102746. https:\/\/doi.org\/10.1016\/j.redox.2023.102746.","journal-title":"Redox Biol"},{"key":"532_CR55","doi-asserted-by":"publisher","unstructured":"Borek I, Birnhuber A, Voelkel NF, Marsh LM, Kwapiszewska G. The vascular perspective on acute and chronic lung disease. J Clin Invest. 2023;133(16). https:\/\/doi.org\/10.1172\/JCI170502.","DOI":"10.1172\/JCI170502"},{"issue":"33","key":"532_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202503014","volume":"12","author":"XX Zhu","year":"2025","unstructured":"Zhu XX, Li H, Zi SF, Tang Y, Liu N, Li KX, et al. tRF-5004b Enriched Secretory Autophagosomes Induce Endothelial Cell Activation to Drive Acute Respiratory Distress Syndrome. Adv Sci (Weinh). 2025;12(33):e03014. https:\/\/doi.org\/10.1002\/advs.202503014.","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"532_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407064","volume":"12","author":"Z Lu","year":"2025","unstructured":"Lu Z, Fang P, Li S, Xia D, Zhang J, Wu X, et al. Lactylation of Histone H3k18 and Egr1 Promotes Endothelial Glycocalyx Degradation in Sepsis-Induced Acute Lung Injury. Adv Sci (Weinh). 2025;12(7):e2407064. https:\/\/doi.org\/10.1002\/advs.202407064.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"532_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12423","volume":"13","author":"L Wang","year":"2024","unstructured":"Wang L, Tang Y, Tang J, Liu X, Zi S, Li S, et al. Endothelial cell-derived extracellular vesicles expressing surface VCAM1 promote sepsis-related acute lung injury by targeting and reprogramming monocytes. J Extracell Vesicles. 2024;13(3):e12423. https:\/\/doi.org\/10.1002\/jev2.12423.","journal-title":"J Extracell Vesicles"},{"issue":"11","key":"532_CR59","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1161\/ATVBAHA.125.322774","volume":"45","author":"A Philippe","year":"2025","unstructured":"Philippe A, Younan R, Gendron N, Peron N, Loyer X, Rancic J, et al. Dexamethasone Suppresses Endotheliopathy and Endothelial-Induced Coagulopathy in COVID-19. Arterioscler Thromb Vasc Biol. 2025;45(11):2069\u201385. https:\/\/doi.org\/10.1161\/ATVBAHA.125.322774.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"532_CR60","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-physiol-042222-030731","volume":"86","author":"DR Price","year":"2024","unstructured":"Price DR, Garcia JGN. A Razor\u2019s Edge: Vascular Responses to Acute Inflammatory Lung Injury\/Acute Respiratory Distress Syndrome. Annu Rev Physiol. 2024;86:505\u201329. https:\/\/doi.org\/10.1146\/annurev-physiol-042222-030731.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"532_CR61","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12964-024-01620-y","volume":"22","author":"X Qiao","year":"2024","unstructured":"Qiao X, Yin J, Zheng Z, Li L, Feng X. Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications. Cell Commun Signal. 2024;22(1):241. https:\/\/doi.org\/10.1186\/s12964-024-01620-y.","journal-title":"Cell Commun Signal"},{"issue":"38","key":"532_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400647","volume":"11","author":"SF Zi","year":"2024","unstructured":"Zi SF, Wu XJ, Tang Y, Liang YP, Liu X, Wang L, et al. Endothelial Cell-Derived Extracellular Vesicles Promote Aberrant Neutrophil Trafficking and Subsequent Remote Lung Injury. Adv Sci (Weinh). 2024;11(38):e2400647. https:\/\/doi.org\/10.1002\/advs.202400647.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"532_CR63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41581-025-01004-6","volume":"22","author":"M Kox","year":"2026","unstructured":"Kox M, Bauer M, Bos LDJ, Bouma H, Calandra T, Calfee CS, et al. The immunology of sepsis: translating new insights into clinical practice. Nat Rev Nephrol. 2026;22(1):30\u201349. https:\/\/doi.org\/10.1038\/s41581-025-01004-6.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"532_CR64","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2024.8772","volume":"332","author":"LB Ware","year":"2024","unstructured":"Ware LB, Files DC, Fowler A, Aboodi MS, Aggarwal NR, Brower RG, et al. Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial. JAMA. 2024;332(5):390\u2013400. https:\/\/doi.org\/10.1001\/jama.2024.8772.","journal-title":"JAMA"},{"key":"532_CR65","doi-asserted-by":"publisher","unstructured":"Fowler AA, 3rd. Vitamin C: Rationale for Its Use in Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS). Antioxidants (Basel). 2024;13(1). https:\/\/doi.org\/10.3390\/antiox13010095.","DOI":"10.3390\/antiox13010095"},{"key":"532_CR66","doi-asserted-by":"publisher","unstructured":"Toya S, Struyf S, Huerta L, Morris P, Gavioli E, Minnella EM, et al. A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome. Eur Respir Rev. 2024;33(173). https:\/\/doi.org\/10.1183\/16000617.0172-2023.","DOI":"10.1183\/16000617.0172-2023"},{"issue":"1","key":"532_CR67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13054-025-05283-0","volume":"29","author":"A Retter","year":"2025","unstructured":"Retter A, Singer M, Annane D. \u201cThe NET effect\u201d: Neutrophil extracellular traps-a potential key component of the dysregulated host immune response in sepsis. Crit Care. 2025;29(1):59. https:\/\/doi.org\/10.1186\/s13054-025-05283-0.","journal-title":"Crit Care"},{"issue":"12","key":"532_CR68","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.7150\/ijbs.99456","volume":"20","author":"HX Sha","year":"2024","unstructured":"Sha HX, Liu YB, Qiu YL, Zhong WJ, Yang NS, Zhang CY, et al. Neutrophil extracellular traps trigger alveolar epithelial cell necroptosis through the cGAS-STING pathway during acute lung injury in mice. Int J Biol Sci. 2024;20(12):4713\u201330. https:\/\/doi.org\/10.7150\/ijbs.99456.","journal-title":"Int J Biol Sci"},{"issue":"10358","key":"532_CR69","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0140-6736(22)01439-8","volume":"400","author":"EA Gorman","year":"2022","unstructured":"Gorman EA, O\u2019Kane CM, McAuley DF. Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management. Lancet. 2022;400(10358):1157\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(22)01439-8.","journal-title":"Lancet"},{"key":"532_CR70","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-med-043021-014005","volume":"74","author":"P Sinha","year":"2023","unstructured":"Sinha P, Meyer NJ, Calfee CS. Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome. Annu Rev Med. 2023;74:457\u201371. https:\/\/doi.org\/10.1146\/annurev-med-043021-014005.","journal-title":"Annu Rev Med"},{"key":"532_CR71","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.freeradbiomed.2024.06.016","volume":"222","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhou W, Zhao J, Chu M, Xu M, Wang X, et al. Regulation of YAP translocation by myeloid Pten deficiency alleviates acute lung injury via inhibition of oxidative stress and inflammation. Free Radic Biol Med. 2024;222:199\u2013210. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.06.016.","journal-title":"Free Radic Biol Med"},{"key":"532_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2026.112361","volume":"140","author":"T Yang","year":"2026","unstructured":"Yang T, Jiang Q, Tan D, Yang H, Shi Y, Zhou J, et al. Jagged1-Notch1\/Foxo1 signaling crosstalk regulates TXNIP\/NLRP3 inflammasome to alleviate lung inflammation. Cell Signal. 2026;140:112361. https:\/\/doi.org\/10.1016\/j.cellsig.2026.112361.","journal-title":"Cell Signal"},{"issue":"1","key":"532_CR73","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1164\/rccm.202303-0472OC","volume":"209","author":"OA Aguilar","year":"2024","unstructured":"Aguilar OA, Qualls AE, Gonzalez-Hinojosa MDR, Obeidalla S, Kerchberger VE, Tsao T, et al. MICB Genomic Variant Is Associated with NKG2D-mediated Acute Lung Injury and Death. Am J Respir Crit Care Med. 2024;209(1):70\u201382. https:\/\/doi.org\/10.1164\/rccm.202303-0472OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"532_CR74","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1186\/cc11425","volume":"16","author":"M Adamzik","year":"2012","unstructured":"Adamzik M, Hamburger T, Petrat F, Peters J, de Groot H, Hartmann M. Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome. Crit Care. 2012;16(4):R125. https:\/\/doi.org\/10.1186\/cc11425.","journal-title":"Crit Care"},{"key":"532_CR75","doi-asserted-by":"publisher","unstructured":"Kerchberger VE, Bastarache JA, Shaver CM, Nagata H, McNeil JB, Landstreet SR, et al. Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis. JCI Insight. 2019;4(21). https:\/\/doi.org\/10.1172\/jci.insight.131206.","DOI":"10.1172\/jci.insight.131206"},{"issue":"5","key":"532_CR76","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura A, Vecchie A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5):319\u201329. https:\/\/doi.org\/10.1038\/s41577-021-00536-9.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"532_CR77","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1172\/JCI141374","volume":"130","author":"P Skendros","year":"2020","unstructured":"Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020;130(11):6151\u20137. https:\/\/doi.org\/10.1172\/JCI141374.","journal-title":"J Clin Invest"},{"issue":"1","key":"532_CR78","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1182\/blood.2019002973","volume":"137","author":"ST Abrams","year":"2021","unstructured":"Abrams ST, Su D, Sahraoui Y, Lin Z, Cheng Z, Nesbitt K, et al. Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation. Blood. 2021;137(1):103\u201314. https:\/\/doi.org\/10.1182\/blood.2019002973.","journal-title":"Blood"},{"issue":"9","key":"532_CR79","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1111\/j.1538-7836.2011.04422.x","volume":"9","author":"CT Ammollo","year":"2011","unstructured":"Ammollo CT, Semeraro F, Xu J, Esmon NL, Esmon CT. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost. 2011;9(9):1795\u2013803. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04422.x.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"532_CR80","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1182\/blood-2011-03-343061","volume":"118","author":"F Semeraro","year":"2011","unstructured":"Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood. 2011;118(7):1952\u201361. https:\/\/doi.org\/10.1182\/blood-2011-03-343061.","journal-title":"Blood"},{"issue":"12","key":"532_CR81","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1182\/blood.2023021915","volume":"144","author":"F Atiq","year":"2024","unstructured":"Atiq F, O\u2019Donnell JS. Novel functions for von Willebrand factor. Blood. 2024;144(12):1247\u201356. https:\/\/doi.org\/10.1182\/blood.2023021915.","journal-title":"Blood"},{"issue":"1","key":"532_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04883-6","volume":"28","author":"PL Valda Toro","year":"2024","unstructured":"Valda Toro PL, Willmore A, Wu NE, Delucchi KL, Jauregui A, Sinha P, et al. Rapidly improving ARDS differs clinically and biologically from persistent ARDS. Crit Care. 2024;28(1):132. https:\/\/doi.org\/10.1186\/s13054-024-04883-6.","journal-title":"Crit Care"},{"issue":"36","key":"532_CR83","doi-asserted-by":"publisher","first-page":"22351","DOI":"10.1073\/pnas.2010229117","volume":"117","author":"S Kang","year":"2020","unstructured":"Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y, et al. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proc Natl Acad Sci U S A. 2020;117(36):22351\u20136. https:\/\/doi.org\/10.1073\/pnas.2010229117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"532_CR84","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01326-2023","author":"CH Mayr","year":"2024","unstructured":"Mayr CH, Sengupta A, Asgharpour S, Ansari M, Pestoni JC, Ogar P, et al. Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts. Eur Respir J. 2024. https:\/\/doi.org\/10.1183\/13993003.01326-2023.","journal-title":"Eur Respir J"},{"issue":"1","key":"532_CR85","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","volume":"25","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I, et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024;25(1):19\u201328. https:\/\/doi.org\/10.1038\/s41590-023-01660-5.","journal-title":"Nat Immunol"},{"issue":"3","key":"532_CR86","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00134-024-07345-3","volume":"50","author":"F Guiouillier","year":"2024","unstructured":"Guiouillier F, Derely J, Salvadori A, Pochard J, Le Goff J, Martinez T, et al. Reactivation of Epstein-Barr virus among intensive care patients: a prospective observational study. Intensive Care Med. 2024;50(3):418\u201326. https:\/\/doi.org\/10.1007\/s00134-024-07345-3.","journal-title":"Intensive Care Med"},{"issue":"8","key":"532_CR87","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00134-024-07529-x","volume":"50","author":"LS Boers","year":"2024","unstructured":"Boers LS, van Someren GF, van Hattem JM, de Brabander J, Zwaan T, van Willigen H, et al. Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19. Intensive Care Med. 2024;50(8):1251\u201364. https:\/\/doi.org\/10.1007\/s00134-024-07529-x.","journal-title":"Intensive Care Med"},{"issue":"11","key":"532_CR88","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1038\/s41591-023-02617-9","volume":"29","author":"E Montassier","year":"2023","unstructured":"Montassier E, Kitsios GD, Radder JE, Le Bastard Q, Kelly BJ, Panzer A, et al. Robust airway microbiome signatures in acute respiratory failure and hospital-acquired pneumonia. Nat Med. 2023;29(11):2793\u2013804. https:\/\/doi.org\/10.1038\/s41591-023-02617-9.","journal-title":"Nat Med"},{"issue":"2","key":"532_CR89","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","volume":"10","author":"JP Gangneux","year":"2022","unstructured":"Gangneux JP, Dannaoui E, Fekkar A, Luyt CE, Botterel F, De Prost N, et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med. 2022;10(2):180\u201390. https:\/\/doi.org\/10.1016\/S2213-2600(21)00442-2.","journal-title":"Lancet Respir Med"},{"key":"532_CR90","doi-asserted-by":"publisher","unstructured":"Maessen L, Boers LS, Heylen J, van Someren Greve F, Wauters J, Bos LDJ, et al. Viral reactivations and fungal infections in nonresolving acute respiratory distress syndrome. Eur Respir Rev. 2025;34(175). https:\/\/doi.org\/10.1183\/16000617.0153-2024.","DOI":"10.1183\/16000617.0153-2024"},{"issue":"11","key":"532_CR91","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro.2017.90","volume":"15","author":"FL van de Veerdonk","year":"2017","unstructured":"van de Veerdonk FL, Gresnigt MS, Romani L, Netea MG, Latge JP. Aspergillus fumigatus morphology and dynamic host interactions. Nat Rev Microbiol. 2017;15(11):661\u201374. https:\/\/doi.org\/10.1038\/nrmicro.2017.90.","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"532_CR92","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","volume":"2","author":"CS Calfee","year":"2014","unstructured":"Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611\u201320. https:\/\/doi.org\/10.1016\/S2213-2600(14)70097-9.","journal-title":"Lancet Respir Med"},{"issue":"10535","key":"532_CR93","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(25)02422-5","volume":"407","author":"M Singer","year":"2026","unstructured":"Singer M, Angus DC, Annane D, Bauer M, Kalil AC, Klompas M, et al. Sepsis Lancet. 2026;407(10535):1276\u201388. https:\/\/doi.org\/10.1016\/S0140-6736(25)02422-5.","journal-title":"Sepsis Lancet"},{"issue":"5","key":"532_CR94","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1165\/rcmb.2024-0201OC","volume":"71","author":"ED Morrell","year":"2024","unstructured":"Morrell ED, Holton SE, Wiedeman A, Kosamo S, Mitchem MA, Dmyterko V, et al. PD-L1 and PD-1 Are Associated with Clinical Outcomes and Alveolar Immune Cell Activation in Acute Respiratory Distress Syndrome. Am J Respir Cell Mol Biol. 2024;71(5):534\u201345. https:\/\/doi.org\/10.1165\/rcmb.2024-0201OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"532_CR95","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/thorax-2023-219989","volume":"78","author":"J de Brabander","year":"2023","unstructured":"de Brabander J, Boers LS, Kullberg RFJ, Zhang S, Nossent EJ, Heunks LMA, et al. Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality. Thorax. 2023;78(9):912\u201321. https:\/\/doi.org\/10.1136\/thorax-2023-219989.","journal-title":"Thorax"},{"issue":"1","key":"532_CR96","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12931-024-02678-5","volume":"25","author":"Q Huang","year":"2024","unstructured":"Huang Q, Le Y, Li S, Bian Y. Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS). Respir Res. 2024;25(1):30. https:\/\/doi.org\/10.1186\/s12931-024-02678-5.","journal-title":"Respir Res"},{"issue":"1","key":"532_CR97","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13054-020-03427-y","volume":"25","author":"I Bendib","year":"2021","unstructured":"Bendib I, Beldi-Ferchiou A, Schlemmer F, Surenaud M, Maitre B, Plonquet A, et al. Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS. Crit Care. 2021;25(1):23. https:\/\/doi.org\/10.1186\/s13054-020-03427-y.","journal-title":"Crit Care"},{"issue":"1","key":"532_CR98","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S2213-2600(21)00157-0","volume":"10","author":"JR Beitler","year":"2022","unstructured":"Beitler JR, Thompson BT, Baron RM, Bastarache JA, Denlinger LC, Esserman L, et al. Advancing precision medicine for acute respiratory distress syndrome. Lancet Respir Med. 2022;10(1):107\u201320. https:\/\/doi.org\/10.1016\/S2213-2600(21)00157-0.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"532_CR99","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/rccm.202311-2086SO","volume":"210","author":"AC Gordon","year":"2024","unstructured":"Gordon AC, Alipanah-Lechner N, Bos LD, Dianti J, Diaz JV, Finfer S, et al. From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU. Am J Respir Crit Care Med. 2024;210(2):155\u201366. https:\/\/doi.org\/10.1164\/rccm.202311-2086SO.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"532_CR100","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1164\/ajrccm\/138.3.720","volume":"138","author":"JF Murray","year":"1988","unstructured":"Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720\u20133. https:\/\/doi.org\/10.1164\/ajrccm\/138.3.720.","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"532_CR101","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF01704707","volume":"20","author":"GR Bernard","year":"1994","unstructured":"Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee Intensive Care Med. 1994;20(3):225\u201332. https:\/\/doi.org\/10.1007\/BF01704707.","journal-title":"The Consensus Committee Intensive Care Med"},{"issue":"10","key":"532_CR102","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1164\/rccm.202308-1368LE","volume":"209","author":"R Liufu","year":"2024","unstructured":"Liufu R, Weng L, Wang CY, Du B. Pitfalls of Acute Respiratory Distress Syndrome Diagnosis Based on Interventions. Am J Respir Crit Care Med. 2024;209(10):1278\u20139. https:\/\/doi.org\/10.1164\/rccm.202308-1368LE.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"532_CR103","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1164\/rccm.202308-1441VP","volume":"209","author":"N Alipanah-Lechner","year":"2024","unstructured":"Alipanah-Lechner N, Cavalcanti AB, Diaz J, Ferguson ND, Myatra SN, Calfee CS. From Berlin to Global: The Need for Syndromic Definitions of Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2024;209(1):21\u20133. https:\/\/doi.org\/10.1164\/rccm.202308-1441VP.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"532_CR104","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1164\/rccm.202308-1369ED","volume":"209","author":"MR Smit","year":"2024","unstructured":"Smit MR, Brower RG, Parsons PE, Phua J, Bos LDJ. The Global Definition of Acute Respiratory Distress Syndrome: Ready for Prime Time? Am J Respir Crit Care Med. 2024;209(1):14\u20136. https:\/\/doi.org\/10.1164\/rccm.202308-1369ED.","journal-title":"Am J Respir Crit Care Med"},{"issue":"25","key":"532_CR105","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMc2029240","volume":"383","author":"MW Sjoding","year":"2020","unstructured":"Sjoding MW, Dickson RP, Iwashyna TJ, Gay SE, Valley TS. Racial Bias in Pulse Oximetry Measurement. N Engl J Med. 2020;383(25):2477\u20138. https:\/\/doi.org\/10.1056\/NEJMc2029240.","journal-title":"N Engl J Med"},{"issue":"4","key":"532_CR106","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/jama.2023.6812","volume":"330","author":"DC Angus","year":"2023","unstructured":"Angus DC, Seymour CW, Bibbins-Domingo K. Caring for Patients With Acute Respiratory Distress Syndrome: Summary of the 2023 ESICM Practice Guidelines. JAMA. 2023;330(4):368\u201371. https:\/\/doi.org\/10.1001\/jama.2023.6812.","journal-title":"JAMA"},{"key":"532_CR107","doi-asserted-by":"publisher","unstructured":"Pham T, Pesenti A, Bellani G, Rubenfeld G, Fan E, Bugedo G, et al. Outcome of acute hypoxaemic respiratory failure: insights from the LUNG SAFE Study. Eur Respir J. 2021;57(6). https:\/\/doi.org\/10.1183\/13993003.03317-2020.","DOI":"10.1183\/13993003.03317-2020"},{"issue":"8","key":"532_CR108","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00134-022-06809-8","volume":"48","author":"L Bitker","year":"2022","unstructured":"Bitker L, Talmor D, Richard JC. Imaging the acute respiratory distress syndrome: past, present and future. Intensive Care Med. 2022;48(8):995\u20131008. https:\/\/doi.org\/10.1007\/s00134-022-06809-8.","journal-title":"Intensive Care Med"},{"issue":"1","key":"532_CR109","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13054-025-05520-6","volume":"29","author":"D Battaglini","year":"2025","unstructured":"Battaglini D, Schultz MJ, Puentes GAC, Marini JJ, Rocco PRM. Imaging and pulmonary function techniques in ARDS diagnosis and management: current insights and challenges. Crit Care. 2025;29(1):282. https:\/\/doi.org\/10.1186\/s13054-025-05520-6.","journal-title":"Crit Care"},{"issue":"6","key":"532_CR110","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s00134-025-07932-y","volume":"51","author":"S Mongodi","year":"2025","unstructured":"Mongodi S, Cortegiani A, Alonso-Ojembarrena A, Biasucci DG, Bos LDJ, Bouhemad B, et al. ESICM-ESPNIC international expert consensus on quantitative lung ultrasound in intensive care. Intensive Care Med. 2025;51(6):1022\u201349. https:\/\/doi.org\/10.1007\/s00134-025-07932-y.","journal-title":"Intensive Care Med"},{"issue":"12","key":"532_CR111","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1164\/rccm.202210-1882OC","volume":"207","author":"MR Smit","year":"2023","unstructured":"Smit MR, Hagens LA, Heijnen NFL, Pisani L, Cherpanath TGV, Dongelmans DA, et al. Lung Ultrasound Prediction Model for Acute Respiratory Distress Syndrome: A Multicenter Prospective Observational Study. Am J Respir Crit Care Med. 2023;207(12):1591\u2013601. https:\/\/doi.org\/10.1164\/rccm.202210-1882OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"532_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102772","volume":"75","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Mei S, Wang J, Xu Q, Zhang Z, Qin S, et al. Development and validation of a deep learning-based framework for automated lung CT segmentation and acute respiratory distress syndrome prediction: a multicenter cohort study. EClinicalMedicine. 2024;75:102772. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102772.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"532_CR113","doi-asserted-by":"publisher","first-page":"6787","DOI":"10.1038\/s41467-025-61418-5","volume":"16","author":"FL Morales","year":"2025","unstructured":"Morales FL, Xu F, Lee HA, Tejedor Navarro H, Bechel MA, Cameron EL, et al. Open-source computational pipeline flags instances of acute respiratory distress syndrome in mechanically ventilated adult patients. Nat Commun. 2025;16(1):6787. https:\/\/doi.org\/10.1038\/s41467-025-61418-5.","journal-title":"Nat Commun"},{"issue":"1","key":"532_CR114","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41746-023-00797-9","volume":"6","author":"N Farzaneh","year":"2023","unstructured":"Farzaneh N, Ansari S, Lee E, Ward KR, Sjoding MW. Collaborative strategies for deploying artificial intelligence to complement physician diagnoses of acute respiratory distress syndrome. NPJ Digit Med. 2023;6(1):62. https:\/\/doi.org\/10.1038\/s41746-023-00797-9.","journal-title":"NPJ Digit Med"},{"issue":"4","key":"532_CR115","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s00134-025-07873-6","volume":"51","author":"DB Antcliffe","year":"2025","unstructured":"Antcliffe DB, Burrell A, Boyle AJ, Gordon AC, McAuley DF, Silversides J. Sepsis subphenotypes, theragnostics and personalized sepsis care. Intensive Care Med. 2025;51(4):756\u201368. https:\/\/doi.org\/10.1007\/s00134-025-07873-6.","journal-title":"Intensive Care Med"},{"issue":"1","key":"532_CR116","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13054-020-2778-x","volume":"24","author":"JG Wilson","year":"2020","unstructured":"Wilson JG, Calfee CS. ARDS Subphenotypes: Understanding a Heterogeneous Syndrome. Crit Care. 2020;24(1):102. https:\/\/doi.org\/10.1186\/s13054-020-2778-x.","journal-title":"Crit Care"},{"key":"532_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.808797","volume":"12","author":"MC Cesta","year":"2021","unstructured":"Cesta MC, Zippoli M, Marsiglia C, Gavioli EM, Mantelli F, Allegretti M, et al. The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome. Front Pharmacol. 2021;12:808797. https:\/\/doi.org\/10.3389\/fphar.2021.808797.","journal-title":"Front Pharmacol"},{"issue":"1","key":"532_CR118","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13054-023-04525-3","volume":"27","author":"CM Rosenberger","year":"2023","unstructured":"Rosenberger CM, Wick KD, Zhuo H, Wu N, Chen Y, Kapadia SB, et al. Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis. Crit Care. 2023;27(1):234. https:\/\/doi.org\/10.1186\/s13054-023-04525-3.","journal-title":"Crit Care"},{"key":"532_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102076","author":"M Jabaudon","year":"2021","unstructured":"Jabaudon M, Pereira B, Laroche E, Roszyk L, Blondonnet R, Audard J, et al. Changes in plasma soluble receptor for advanced glycation end-products are associated with survival in patients with acute respiratory distress syndrome. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10102076.","journal-title":"J Clin Med"},{"key":"532_CR120","doi-asserted-by":"publisher","unstructured":"Yehya N, Booth TJ, Ardhanari GD, Thompson JM, Lam LKM, Till JE, et al. Inflammatory and tissue injury marker dynamics in pediatric acute respiratory distress syndrome. J Clin Invest. 2024;134(10). https:\/\/doi.org\/10.1172\/JCI177896.","DOI":"10.1172\/JCI177896"},{"issue":"5","key":"532_CR121","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1164\/rccm.202302-0314LE","volume":"208","author":"TK Jones","year":"2023","unstructured":"Jones TK, Reilly JP, Anderson BJ, Miano TA, Dunn TG, Turner AP, et al. Acute Respiratory Distress Syndrome Mediates the Association between Early Plasma Soluble Receptor for Advanced Glycation End Products Concentrations and Mortality in Sepsis. Am J Respir Crit Care Med. 2023;208(5):628\u201330. https:\/\/doi.org\/10.1164\/rccm.202302-0314LE.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"532_CR122","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00134-018-5328-0","volume":"44","author":"JP Reilly","year":"2018","unstructured":"Reilly JP, Wang F, Jones TK, Palakshappa JA, Anderson BJ, Shashaty MGS, et al. Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis. Intensive Care Med. 2018;44(11):1849\u201358. https:\/\/doi.org\/10.1007\/s00134-018-5328-0.","journal-title":"Intensive Care Med"},{"issue":"1","key":"532_CR123","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1164\/rccm.201810-2033OC","volume":"201","author":"TK Jones","year":"2020","unstructured":"Jones TK, Feng R, Kerchberger VE, Reilly JP, Anderson BJ, Shashaty MGS, et al. Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020;201(1):47\u201356. https:\/\/doi.org\/10.1164\/rccm.201810-2033OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"532_CR124","doi-asserted-by":"publisher","unstructured":"Mi Y, Burnham KL, Charles PD, Heilig R, Vendrell I, Whalley J, et al. High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response. Sci Transl Med. 2024;16(750):eadh0185. https:\/\/doi.org\/10.1126\/scitranslmed.adh0185.","DOI":"10.1126\/scitranslmed.adh0185"},{"key":"532_CR125","doi-asserted-by":"publisher","unstructured":"Viode A, Smolen KK, van Zalm P, Stevenson D, Jha M, Parker K, et al. Longitudinal plasma proteomic analysis of 1117 hospitalized patients with COVID-19 identifies features associated with severity and outcomes. Sci Adv. 2024;10(21):eadl5762. https:\/\/doi.org\/10.1126\/sciadv.adl5762.","DOI":"10.1126\/sciadv.adl5762"},{"issue":"11","key":"532_CR126","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1007\/s00134-024-07593-3","volume":"50","author":"N Bruse","year":"2024","unstructured":"Bruse N, Motos A, van Amstel R, de Bie E, Kooistra EJ, Jansen A, et al. Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients. Intensive Care Med. 2024;50(11):1884\u201396. https:\/\/doi.org\/10.1007\/s00134-024-07593-3.","journal-title":"Intensive Care Med"},{"issue":"1","key":"532_CR127","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s13054-021-03734-y","volume":"25","author":"X Liu","year":"2021","unstructured":"Liu X, Jiang Y, Jia X, Ma X, Han C, Guo N, et al. Identification of distinct clinical phenotypes of acute respiratory distress syndrome with differential responses to treatment. Crit Care. 2021;25(1):320. https:\/\/doi.org\/10.1186\/s13054-021-03734-y.","journal-title":"Crit Care"},{"issue":"1","key":"532_CR128","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12931-024-02910-2","volume":"25","author":"F van der Ven","year":"2024","unstructured":"van der Ven F, Blok SG, Azevedo LC, Bellani G, Botta M, Estenssoro E, et al. Epidemiology, ventilation management and outcomes of COVID-19 ARDS patients versus patients with ARDS due to pneumonia in the Pre-COVID era. Respir Res. 2024;25(1):312. https:\/\/doi.org\/10.1186\/s12931-024-02910-2.","journal-title":"Respir Res"},{"issue":"1","key":"532_CR129","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s13054-022-04251-2","volume":"26","author":"DFL Filippini","year":"2022","unstructured":"Filippini DFL, Di Gennaro E, van Amstel RBE, Beenen LFM, Grasso S, Pisani L, et al. Latent class analysis of imaging and clinical respiratory parameters from patients with COVID-19-related ARDS identifies recruitment subphenotypes. Crit Care. 2022;26(1):363. https:\/\/doi.org\/10.1186\/s13054-022-04251-2.","journal-title":"Crit Care"},{"issue":"1","key":"532_CR130","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13054-021-03578-6","volume":"25","author":"PD Wendel Garcia","year":"2021","unstructured":"Wendel Garcia PD, Caccioppola A, Coppola S, Pozzi T, Ciabattoni A, Cenci S, et al. Latent class analysis to predict intensive care outcomes in Acute Respiratory Distress Syndrome: a proposal of two pulmonary phenotypes. Crit Care. 2021;25(1):154. https:\/\/doi.org\/10.1186\/s13054-021-03578-6.","journal-title":"Crit Care"},{"issue":"1","key":"532_CR131","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13054-021-03541-5","volume":"25","author":"D Kudo","year":"2021","unstructured":"Kudo D, Goto T, Uchimido R, Hayakawa M, Yamakawa K, Abe T, et al. Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies. Crit Care. 2021;25(1):114. https:\/\/doi.org\/10.1186\/s13054-021-03541-5.","journal-title":"Crit Care"},{"issue":"11","key":"532_CR132","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S2213-2600(23)00237-0","volume":"11","author":"P Sinha","year":"2023","unstructured":"Sinha P, Kerchberger VE, Willmore A, Chambers J, Zhuo H, Abbott J, et al. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. Lancet Respir Med. 2023;11(11):965\u201374. https:\/\/doi.org\/10.1016\/S2213-2600(23)00237-0.","journal-title":"Lancet Respir Med"},{"issue":"7","key":"532_CR133","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1164\/rccm.202409-1816RL","volume":"211","author":"GD Kitsios","year":"2025","unstructured":"Kitsios GD, Haque M, Bain WG, Dela Cruz C, McVerry BJ, Shah FA, et al. Clinician Prediction of Hyperinflammatory Acute Respiratory Distress Syndrome Subphenotypes: Overestimated but Prognostic. Am J Respir Crit Care Med. 2025;211(7):1294\u20137. https:\/\/doi.org\/10.1164\/rccm.202409-1816RL.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"532_CR134","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00134-023-07244-z","volume":"49","author":"S Redaelli","year":"2023","unstructured":"Redaelli S, von Wedel D, Fosset M, Suleiman A, Chen G, Alingrin J, et al. Inflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial. Intensive Care Med. 2023;49(12):1499\u2013507. https:\/\/doi.org\/10.1007\/s00134-023-07244-z.","journal-title":"Intensive Care Med"},{"issue":"9","key":"532_CR135","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","volume":"6","author":"CS Calfee","year":"2018","unstructured":"Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med. 2018;6(9):691\u20138. https:\/\/doi.org\/10.1016\/S2213-2600(18)30177-2.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"532_CR136","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S2213-2600(21)00461-6","volume":"10","author":"MV Maddali","year":"2022","unstructured":"Maddali MV, Churpek M, Pham T, Rezoagli E, Zhuo H, Zhao W, et al. Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis. Lancet Respir Med. 2022;10(4):367\u201377. https:\/\/doi.org\/10.1016\/S2213-2600(21)00461-6.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"532_CR137","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1164\/rccm.201603-0645OC","volume":"195","author":"KR Famous","year":"2017","unstructured":"Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, et al. Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy. Am J Respir Crit Care Med. 2017;195(3):331\u20138. https:\/\/doi.org\/10.1164\/rccm.201603-0645OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"532_CR138","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1164\/rccm.202308-1328OC","volume":"209","author":"LPA Neyton","year":"2024","unstructured":"Neyton LPA, Sinha P, Sarma A, Mick E, Kalantar K, Chen S, et al. Host and microbe blood metagenomics reveals key pathways characterizing critical illness phenotypes. Am J Respir Crit Care Med. 2024;209(7):805\u201315. https:\/\/doi.org\/10.1164\/rccm.202308-1328OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"532_CR139","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1038\/s41467-023-39593-0","volume":"14","author":"T Flerlage","year":"2023","unstructured":"Flerlage T, Crawford JC, Allen EK, Severns D, Tan S, Surman S, et al. Single cell transcriptomics identifies distinct profiles in pediatric acute respiratory distress syndrome. Nat Commun. 2023;14(1):3870. https:\/\/doi.org\/10.1038\/s41467-023-39593-0.","journal-title":"Nat Commun"},{"key":"532_CR140","doi-asserted-by":"publisher","unstructured":"Lopez-Martinez C, Martin-Vicente P, Gomez de Ona J, Lopez-Alonso I, Gil-Pena H, Cuesta-Llavona E, et al. Transcriptomic clustering of critically ill COVID-19 patients. Eur Respir J. 2023;61(1). https:\/\/doi.org\/10.1183\/13993003.00592-2022.","DOI":"10.1183\/13993003.00592-2022"},{"key":"532_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105951","volume":"120","author":"B Guillen-Guio","year":"2025","unstructured":"Guillen-Guio B, Suarez-Pajes E, Tosco-Herrera E, Hernandez-Beeftink T, Lorenzo-Salazar JM, Chang D, et al. Genome-wide association study of susceptibility to acute respiratory distress syndrome. EBioMedicine. 2025;120:105951. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105951.","journal-title":"EBioMedicine"},{"issue":"7","key":"532_CR142","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1164\/rccm.202308-1490OC","volume":"209","author":"P Sinha","year":"2024","unstructured":"Sinha P, Neyton L, Sarma A, Wu N, Jones C, Zhuo H, et al. Molecular Phenotypes of Acute Respiratory Distress Syndrome in the ROSE Trial Have Differential Outcomes and Gene Expression Patterns That Differ at Baseline and Longitudinally over Time. Am J Respir Crit Care Med. 2024;209(7):816\u201328. https:\/\/doi.org\/10.1164\/rccm.202308-1490OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"532_CR143","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00933-2025","author":"M Lin","year":"2025","unstructured":"Lin M, Xu F, Deng Y, Wei Y, Shi F, Xie Y, et al. Large-scale proteomic profiling identifies distinct inflammatory phenotypes in Acute Respiratory Distress Syndrome (ARDS): A multi-center, prospective cohort study. Eur Respir J. 2025. https:\/\/doi.org\/10.1183\/13993003.00933-2025.","journal-title":"Eur Respir J"},{"issue":"10","key":"532_CR144","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s00134-025-08089-4","volume":"51","author":"J Pensier","year":"2025","unstructured":"Pensier J, Fosset M, Paschold BS, von Wedel D, Redaelli S, Braeuer BLP, et al. Temporal stability of phenotypes of acute respiratory distress syndrome: clinical implications for early corticosteroid therapy and mortality. Intensive Care Med. 2025;51(10):1784\u201396. https:\/\/doi.org\/10.1007\/s00134-025-08089-4.","journal-title":"Intensive Care Med"},{"issue":"3","key":"532_CR145","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.202406-1241OC","volume":"211","author":"RBE van Amstel","year":"2025","unstructured":"van Amstel RBE, Bartek B, Vlaar APJ, Gay E, van Vught LA, Cremer OL, et al. Temporal Transitions of the Hyperinflammatory and Hypoinflammatory Phenotypes in Critical Illness. Am J Respir Crit Care Med. 2025;211(3):347\u201356. https:\/\/doi.org\/10.1164\/rccm.202406-1241OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"532_CR146","doi-asserted-by":"publisher","unstructured":"Acute Respiratory Distress Syndrome N, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301\u20138. https:\/\/doi.org\/10.1056\/NEJM200005043421801.","DOI":"10.1056\/NEJM200005043421801"},{"issue":"23","key":"532_CR147","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","volume":"368","author":"C Guerin","year":"2013","unstructured":"Guerin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159\u201368. https:\/\/doi.org\/10.1056\/NEJMoa1214103.","journal-title":"N Engl J Med"},{"issue":"7","key":"532_CR148","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00134-024-07492-7","volume":"50","author":"S Sud","year":"2024","unstructured":"Sud S, Fan E, Adhikari NKJ, Friedrich JO, Ferguson ND, Combes A, et al. Comparison of venovenous extracorporeal membrane oxygenation, prone position and supine mechanical ventilation for severely hypoxemic acute respiratory distress syndrome: a network meta-analysis. Intensive Care Med. 2024;50(7):1021\u201334. https:\/\/doi.org\/10.1007\/s00134-024-07492-7.","journal-title":"Intensive Care Med"},{"key":"532_CR149","doi-asserted-by":"publisher","unstructured":"National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564\u201375. https:\/\/doi.org\/10.1056\/NEJMoa062200.","DOI":"10.1056\/NEJMoa062200"},{"issue":"11","key":"532_CR150","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1164\/rccm.202401-0049OC","volume":"210","author":"E Papoutsi","year":"2024","unstructured":"Papoutsi E, Gkirgkiris K, Tsolaki V, Andrianopoulos I, Pontikis K, Vaporidi K, et al. Association Between Baseline Driving Pressure and Mortality in Very Old Patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2024;210(11):1329\u201337. https:\/\/doi.org\/10.1164\/rccm.202401-0049OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"532_CR151","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00134-023-06996-y","volume":"49","author":"E Papoutsi","year":"2023","unstructured":"Papoutsi E, Routsi C, Kotanidou A, Vaporidi K, Siempos II. Association between driving pressure and mortality may depend on timing since onset of acute respiratory distress syndrome. Intensive Care Med. 2023;49(3):363\u20135. https:\/\/doi.org\/10.1007\/s00134-023-06996-y.","journal-title":"Intensive Care Med"},{"issue":"5","key":"532_CR152","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00134-024-07362-2","volume":"50","author":"N Songsangvorn","year":"2024","unstructured":"Songsangvorn N, Xu Y, Lu C, Rotstein O, Brochard L, Slutsky AS, et al. Electrical impedance tomography-guided positive end-expiratory pressure titration in ARDS: a systematic review and meta-analysis. Intensive Care Med. 2024;50(5):617\u201331. https:\/\/doi.org\/10.1007\/s00134-024-07362-2.","journal-title":"Intensive Care Med"},{"issue":"12","key":"532_CR153","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s00134-024-07695-y","volume":"50","author":"T Mauri","year":"2024","unstructured":"Mauri T, Grieco DL, Spinelli E, Leali M, Perez J, Chiavieri V, et al. Personalized positive end-expiratory pressure in spontaneously breathing patients with acute respiratory distress syndrome by simultaneous electrical impedance tomography and transpulmonary pressure monitoring: a randomized crossover trial. Intensive Care Med. 2024;50(12):2125\u201337. https:\/\/doi.org\/10.1007\/s00134-024-07695-y.","journal-title":"Intensive Care Med"},{"issue":"1","key":"532_CR154","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1164\/rccm.202212-2300OC","volume":"208","author":"AH Jonkman","year":"2023","unstructured":"Jonkman AH, Alcala GC, Pavlovsky B, Roca O, Spadaro S, Scaramuzzo G, et al. Lung Recruitment Assessed by Electrical Impedance Tomography (RECRUIT): A Multicenter Study of COVID-19 Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2023;208(1):25\u201338. https:\/\/doi.org\/10.1164\/rccm.202212-2300OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"532_CR155","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13054-025-05263-4","volume":"29","author":"S Giovanazzi","year":"2025","unstructured":"Giovanazzi S, Nocera D, Catozzi G, Collino F, Cressoni M, Ball L, et al. Assessment of recruitment from CT to the bedside: challenges and future directions. Crit Care. 2025;29(1):64. https:\/\/doi.org\/10.1186\/s13054-025-05263-4.","journal-title":"Crit Care"},{"issue":"1","key":"532_CR156","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13054-022-04198-4","volume":"26","author":"D Slobod","year":"2022","unstructured":"Slobod D, Leali M, Spinelli E, Grieco DL, Spadaro S, Mauri T. Integrating electrical impedance tomography and transpulmonary pressure monitoring to personalize PEEP in hypoxemic patients undergoing pressure support ventilation. Crit Care. 2022;26(1):314. https:\/\/doi.org\/10.1186\/s13054-022-04198-4.","journal-title":"Crit Care"},{"issue":"7","key":"532_CR157","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/s00134-024-07440-5","volume":"50","author":"M Pellegrini","year":"2024","unstructured":"Pellegrini M, Del Sorbo L, Ranieri VM. Finding the optimal tidal volume in acute respiratory distress syndrome. Intensive Care Med. 2024;50(7):1154\u20136. https:\/\/doi.org\/10.1007\/s00134-024-07440-5.","journal-title":"Intensive Care Med"},{"issue":"11","key":"532_CR158","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMoa1916431","volume":"382","author":"L Barrot","year":"2020","unstructured":"Barrot L, Asfar P, Mauny F, Winiszewski H, Montini F, Badie J, et al. Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome. N Engl J Med. 2020;382(11):999\u20131008. https:\/\/doi.org\/10.1056\/NEJMoa1916431.","journal-title":"N Engl J Med"},{"issue":"11","key":"532_CR159","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMe2000800","volume":"382","author":"DC Angus","year":"2020","unstructured":"Angus DC. Oxygen Therapy for the Critically Ill. N Engl J Med. 2020;382(11):1054\u20136. https:\/\/doi.org\/10.1056\/NEJMe2000800.","journal-title":"N Engl J Med"},{"issue":"7","key":"532_CR160","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1164\/rccm.202303-0560OC","volume":"208","author":"LI van der Wal","year":"2023","unstructured":"van der Wal LI, Grim CCA, Del Prado MR, van Westerloo DJ, Boerma EC, Rijnhart-de Jong HG, et al. Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial. Am J Respir Crit Care Med. 2023;208(7):770\u20139. https:\/\/doi.org\/10.1164\/rccm.202303-0560OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"532_CR161","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jama.2021.13011","volume":"326","author":"H Gelissen","year":"2021","unstructured":"Gelissen H, de Grooth HJ, Smulders Y, Wils EJ, de Ruijter W, Vink R, et al. Effect of Low-Normal vs High-Normal Oxygenation Targets on Organ Dysfunction in Critically Ill Patients: A Randomized Clinical Trial. JAMA. 2021;326(10):940\u20138. https:\/\/doi.org\/10.1001\/jama.2021.13011.","journal-title":"JAMA"},{"issue":"19","key":"532_CR162","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1056\/NEJMoa2208415","volume":"387","author":"MW Semler","year":"2022","unstructured":"Semler MW, Casey JD, Lloyd BD, Hastings PG, Hays MA, Stollings JL, et al. Oxygen-Saturation Targets for Critically Ill Adults Receiving Mechanical Ventilation. N Engl J Med. 2022;387(19):1759\u201369. https:\/\/doi.org\/10.1056\/NEJMoa2208415.","journal-title":"N Engl J Med"},{"issue":"6","key":"532_CR163","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jama.2024.25786","volume":"333","author":"T Arleth","year":"2025","unstructured":"Arleth T, Baekgaard J, Siersma V, Creutzburg A, Dinesen F, Rosenkrantz O, et al. Early Restrictive vs Liberal Oxygen for Trauma Patients: The TRAUMOX2 Randomized Clinical Trial. JAMA. 2025;333(6):479\u201389. https:\/\/doi.org\/10.1001\/jama.2024.25786.","journal-title":"JAMA"},{"issue":"1","key":"532_CR164","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13613-024-01300-7","volume":"14","author":"XY Li","year":"2024","unstructured":"Li XY, Dai B, Hou HJ, Zhao HW, Wang W, Kang J, et al. Conservative versus liberal oxygen therapy for intensive care unit patients: meta-analysis of randomized controlled trials. Ann Intensive Care. 2024;14(1):68. https:\/\/doi.org\/10.1186\/s13613-024-01300-7.","journal-title":"Ann Intensive Care"},{"key":"532_CR165","doi-asserted-by":"publisher","unstructured":"Investigators IR, the A, New Zealand Intensive Care Society Clinical Trials G, Mackle D, Bellomo R, Bailey M, et al. Conservative Oxygen Therapy during Mechanical Ventilation in the ICU. N Engl J Med. 2020;382(11):989\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1903297.","DOI":"10.1056\/NEJMoa1903297"},{"issue":"14","key":"532_CR166","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJMoa2032510","volume":"384","author":"OL Schjorring","year":"2021","unstructured":"Schjorring OL, Klitgaard TL, Perner A, Wetterslev J, Lange T, Siegemund M, et al. Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure. N Engl J Med. 2021;384(14):1301\u201311. https:\/\/doi.org\/10.1056\/NEJMoa2032510.","journal-title":"N Engl J Med"},{"issue":"5","key":"532_CR167","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1001\/jama.2025.9663","volume":"334","author":"DS Martin","year":"2025","unstructured":"Martin DS, Gould DW, Shahid T, Doidge JC, Cowden A, Sadique Z, et al. Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients: The UK-ROX Randomized Clinical Trial. JAMA. 2025;334(5):398\u2013408. https:\/\/doi.org\/10.1001\/jama.2025.9663.","journal-title":"JAMA"},{"issue":"10424","key":"532_CR168","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0140-6736(23)01968-2","volume":"403","author":"MJ Peters","year":"2024","unstructured":"Peters MJ, Gould DW, Ray S, Thomas K, Chang I, Orzol M, et al. Conservative versus liberal oxygenation targets in critically ill children (Oxy-PICU): a UK multicentre, open, parallel-group, randomised clinical trial. Lancet. 2024;403(10424):355\u201364. https:\/\/doi.org\/10.1016\/S0140-6736(23)01968-2.","journal-title":"Lancet"},{"issue":"14","key":"532_CR169","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1001\/jama.2024.2934","volume":"331","author":"FM Nielsen","year":"2024","unstructured":"Nielsen FM, Klitgaard TL, Siegemund M, Laake JH, Thormar KM, Cole JM, et al. Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial. JAMA. 2024;331(14):1185\u201394. https:\/\/doi.org\/10.1001\/jama.2024.2934.","journal-title":"JAMA"},{"issue":"22","key":"532_CR170","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1001\/jama.2021.20552","volume":"326","author":"DC Angus","year":"2021","unstructured":"Angus DC, Chang CH. Heterogeneity of Treatment Effect: Estimating How the Effects of Interventions Vary Across Individuals. JAMA. 2021;326(22):2312\u20133. https:\/\/doi.org\/10.1001\/jama.2021.20552.","journal-title":"JAMA"},{"issue":"1","key":"532_CR171","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13054-025-05254-5","volume":"29","author":"DS Martin","year":"2025","unstructured":"Martin DS, Grocott MPW. Heterogeneity of treatment effect: the case for individualising oxygen therapy in critically ill patients. Crit Care. 2025;29(1):50. https:\/\/doi.org\/10.1186\/s13054-025-05254-5.","journal-title":"Crit Care"},{"issue":"14","key":"532_CR172","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jama.2024.2933","volume":"331","author":"KG Buell","year":"2024","unstructured":"Buell KG, Spicer AB, Casey JD, Seitz KP, Qian ET, Graham Linck EJ, et al. Individualized Treatment Effects of Oxygen Targets in Mechanically Ventilated Critically Ill Adults. JAMA. 2024;331(14):1195\u2013204. https:\/\/doi.org\/10.1001\/jama.2024.2933.","journal-title":"JAMA"},{"issue":"14","key":"532_CR173","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jama.2024.3376","volume":"331","author":"G Wang","year":"2024","unstructured":"Wang G, Heagerty PJ, Dahabreh IJ. Using Effect Scores to Characterize Heterogeneity of Treatment Effects. JAMA. 2024;331(14):1225\u20136. https:\/\/doi.org\/10.1001\/jama.2024.3376.","journal-title":"JAMA"},{"issue":"23","key":"532_CR174","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","volume":"372","author":"JP Frat","year":"2015","unstructured":"Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185\u201396. https:\/\/doi.org\/10.1056\/NEJMoa1503326.","journal-title":"N Engl J Med"},{"issue":"20","key":"532_CR175","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1001\/jama.2018.14282","volume":"320","author":"E Azoulay","year":"2018","unstructured":"Azoulay E, Lemiale V, Mokart D, Nseir S, Argaud L, Pene F, et al. Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial. JAMA. 2018;320(20):2099\u2013107. https:\/\/doi.org\/10.1001\/jama.2018.14282.","journal-title":"JAMA"},{"issue":"7","key":"532_CR176","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S2213-2600(22)00096-0","volume":"10","author":"R Coudroy","year":"2022","unstructured":"Coudroy R, Frat JP, Ehrmann S, Pene F, Decavele M, Terzi N, et al. High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial. Lancet Respir Med. 2022;10(7):641\u20139. https:\/\/doi.org\/10.1016\/S2213-2600(22)00096-0.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"532_CR177","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00134-025-07890-5","volume":"51","author":"E Azoulay","year":"2025","unstructured":"Azoulay E, Metais M, Lemiale V, Mokart D, Moreau AS, Canet E, et al. Outcomes in immunocompromised patients with acute hypoxemic respiratory failure treated by high-flow nasal oxygen. Intensive Care Med. 2025;51(4):731\u201341. https:\/\/doi.org\/10.1007\/s00134-025-07890-5.","journal-title":"Intensive Care Med"},{"key":"532_CR178","doi-asserted-by":"publisher","unstructured":"Richard JM, Beloncle FM, Beduneau G, Mortaza S, Ehrmann S, Diehl JL, et al. Pressure control plus spontaneous ventilation versus volume assist-control ventilation in acute respiratory distress syndrome. A randomised clinical trial. Intensive Care Med. 2024;50(10):1647\u201356. https:\/\/doi.org\/10.1007\/s00134-024-07612-3.","DOI":"10.1007\/s00134-024-07612-3"},{"issue":"11","key":"532_CR179","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1007\/s00134-020-06248-3","volume":"46","author":"A Combes","year":"2020","unstructured":"Combes A, Peek GJ, Hajage D, Hardy P, Abrams D, Schmidt M, et al. ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med. 2020;46(11):2048\u201357. https:\/\/doi.org\/10.1007\/s00134-020-06248-3.","journal-title":"Intensive Care Med"},{"issue":"21","key":"532_CR180","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","volume":"378","author":"A Combes","year":"2018","unstructured":"Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med. 2018;378(21):1965\u201375. https:\/\/doi.org\/10.1056\/NEJMoa1800385.","journal-title":"N Engl J Med"},{"issue":"9698","key":"532_CR181","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/S0140-6736(09)61069-2","volume":"374","author":"GJ Peek","year":"2009","unstructured":"Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(09)61069-2.","journal-title":"Lancet"},{"issue":"9","key":"532_CR182","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1007\/s00134-025-08070-1","volume":"51","author":"A Combes","year":"2025","unstructured":"Combes A, Supady A, Abrams D, Agerstrand C, Badulak J, Camporota L, et al. Extracorporeal life support for adult patients with ARDS. Intensive Care Med. 2025;51(9):1674\u201386. https:\/\/doi.org\/10.1007\/s00134-025-08070-1.","journal-title":"Intensive Care Med"},{"issue":"2","key":"532_CR183","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S2213-2600(22)00403-9","volume":"11","author":"R Lorusso","year":"2023","unstructured":"Lorusso R, De Piero ME, Mariani S, Di Mauro M, Folliguet T, Taccone FS, et al. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study. Lancet Respir Med. 2023;11(2):151\u201362. https:\/\/doi.org\/10.1016\/S2213-2600(22)00403-9.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"532_CR184","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S2213-2600(22)00438-6","volume":"11","author":"M Schmidt","year":"2023","unstructured":"Schmidt M, Hajage D, Landoll M, Pequignot B, Langouet E, Amalric M, et al. Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study. Lancet Respir Med. 2023;11(2):163\u201375. https:\/\/doi.org\/10.1016\/S2213-2600(22)00438-6.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"532_CR185","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00134-024-07343-5","volume":"50","author":"SM Fernando","year":"2024","unstructured":"Fernando SM, Brodie D, Barbaro RP, Agerstrand C, Badulak J, Bush EL, et al. Age and associated outcomes among patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory failure: analysis of the Extracorporeal Life Support Organization registry. Intensive Care Med. 2024;50(3):395\u2013405. https:\/\/doi.org\/10.1007\/s00134-024-07343-5.","journal-title":"Intensive Care Med"},{"issue":"1","key":"532_CR186","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13054-024-05074-z","volume":"28","author":"T Tonetti","year":"2024","unstructured":"Tonetti T, Di Staso R, Bambini L, Bordini M, D\u2019Albo R, Nocera D, et al. Role of age as eligibility criterion for ECMO in patients with ARDS: meta-regression analysis. Crit Care. 2024;28(1):278. https:\/\/doi.org\/10.1186\/s13054-024-05074-z.","journal-title":"Crit Care"},{"issue":"3","key":"532_CR187","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2213-2600(22)00296-X","volume":"11","author":"A Tran","year":"2023","unstructured":"Tran A, Fernando SM, Rochwerg B, Barbaro RP, Hodgson CL, Munshi L, et al. Prognostic factors associated with mortality among patients receiving venovenous extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis. Lancet Respir Med. 2023;11(3):235\u201344. https:\/\/doi.org\/10.1016\/S2213-2600(22)00296-X.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"532_CR188","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1164\/rccm.202309-1688OC","volume":"210","author":"E Spinelli","year":"2024","unstructured":"Spinelli E, Giani M, Slobod D, Pavlovsky B, di Pierro M, Crotti S, et al. Physiologic Effects of Extracorporeal Membrane Oxygenation in Patients with Severe Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2024;210(5):629\u201338. https:\/\/doi.org\/10.1164\/rccm.202309-1688OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"532_CR189","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s00134-020-06306-w","volume":"46","author":"C Guerin","year":"2020","unstructured":"Guerin C, Albert RK, Beitler J, Gattinoni L, Jaber S, Marini JJ, et al. Prone position in ARDS patients: why, when, how and for whom. Intensive Care Med. 2020;46(12):2385\u201396. https:\/\/doi.org\/10.1007\/s00134-020-06306-w.","journal-title":"Intensive Care Med"},{"issue":"24","key":"532_CR190","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1001\/jama.2023.24491","volume":"330","author":"M Schmidt","year":"2023","unstructured":"Schmidt M, Hajage D, Lebreton G, Dres M, Guervilly C, Richard JC, et al. Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS: The PRONECMO Randomized Clinical Trial. JAMA. 2023;330(24):2343\u201353. https:\/\/doi.org\/10.1001\/jama.2023.24491.","journal-title":"JAMA"},{"issue":"1","key":"532_CR191","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s13054-022-04272-x","volume":"26","author":"C Guervilly","year":"2022","unstructured":"Guervilly C, Fournier T, Chommeloux J, Arnaud L, Pinglis C, Baumstarck K, et al. Ultra-lung-protective ventilation and biotrauma in severe ARDS patients on veno-venous extracorporeal membrane oxygenation: a randomized controlled study. Crit Care. 2022;26(1):383. https:\/\/doi.org\/10.1186\/s13054-022-04272-x.","journal-title":"Crit Care"},{"issue":"3","key":"532_CR192","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00134-021-06604-x","volume":"48","author":"L Papazian","year":"2022","unstructured":"Papazian L, Schmidt M, Hajage D, Combes A, Petit M, Lebreton G, et al. Effect of prone positioning on survival in adult patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Intensive Care Med. 2022;48(3):270\u201380. https:\/\/doi.org\/10.1007\/s00134-021-06604-x.","journal-title":"Intensive Care Med"},{"key":"532_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2025.111786","volume":"103","author":"PH Chen","year":"2025","unstructured":"Chen PH, Lee CH, Yen WT, Lee CC, Jhou HJ, Wu CS, et al. Efficacy and safety of prone positioning in patients undergoing extracorporeal membrane oxygenation (ECMO): A systematic review and meta-analysis. J Clin Anesth. 2025;103:111786. https:\/\/doi.org\/10.1016\/j.jclinane.2025.111786.","journal-title":"J Clin Anesth"},{"issue":"1","key":"532_CR194","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/CCM.0000000000005705","volume":"51","author":"M Giani","year":"2023","unstructured":"Giani M, Rezoagli E, Guervilly C, Rilinger J, Duburcq T, Petit M, et al. Timing of Prone Positioning During Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. Crit Care Med. 2023;51(1):25\u201335. https:\/\/doi.org\/10.1097\/CCM.0000000000005705.","journal-title":"Crit Care Med"},{"issue":"10257","key":"532_CR195","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0140-6736(20)32008-0","volume":"396","author":"RP Barbaro","year":"2020","unstructured":"Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020;396(10257):1071\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(20)32008-0.","journal-title":"Lancet"},{"issue":"10307","key":"532_CR196","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/S0140-6736(21)01960-7","volume":"398","author":"RP Barbaro","year":"2021","unstructured":"Barbaro RP, MacLaren G, Boonstra PS, Combes A, Agerstrand C, Annich G, et al. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet. 2021;398(10307):1230\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(21)01960-7.","journal-title":"Lancet"},{"issue":"6","key":"532_CR197","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s00134-024-07368-w","volume":"50","author":"D Abrams","year":"2024","unstructured":"Abrams D, Guervilly C, Brodie D. Prone positioning during extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Not sure Intensive Care Med. 2024;50(6):950\u20132. https:\/\/doi.org\/10.1007\/s00134-024-07368-w.","journal-title":"Not sure Intensive Care Med"},{"issue":"10","key":"532_CR198","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1007\/s00134-013-3037-2","volume":"39","author":"M Schmidt","year":"2013","unstructured":"Schmidt M, Zogheib E, Roze H, Repesse X, Lebreton G, Luyt CE, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med. 2013;39(10):1704\u201313. https:\/\/doi.org\/10.1007\/s00134-013-3037-2.","journal-title":"Intensive Care Med"},{"issue":"6","key":"532_CR199","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00134-024-07371-1","volume":"50","author":"M Schmidt","year":"2024","unstructured":"Schmidt M, Kimmoun A, Combes A. Prone positioning during extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Con Intensive Care Med. 2024;50(6):947\u20139. https:\/\/doi.org\/10.1007\/s00134-024-07371-1.","journal-title":"Con Intensive Care Med"},{"issue":"6","key":"532_CR200","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s00134-024-07449-w","volume":"50","author":"M Giani","year":"2024","unstructured":"Giani M, Papazian L, Grasselli G. Prone positioning during extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Pro Intensive Care Med. 2024;50(6):944\u20136. https:\/\/doi.org\/10.1007\/s00134-024-07449-w.","journal-title":"Pro Intensive Care Med"},{"issue":"8","key":"532_CR201","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1164\/rccm.202110-2252CP","volume":"205","author":"D Abrams","year":"2022","unstructured":"Abrams D, Agerstrand C, Beitler JR, Karagiannidis C, Madahar P, Yip NH, et al. Risks and Benefits of Ultra-Lung-Protective Invasive Mechanical Ventilation Strategies with a Focus on Extracorporeal Support. Am J Respir Crit Care Med. 2022;205(8):873\u201382. https:\/\/doi.org\/10.1164\/rccm.202110-2252CP.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"532_CR202","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00134-024-07690-3","volume":"50","author":"M Olmos","year":"2024","unstructured":"Olmos M, Esperatti M, Fuentes N, Miranda Tirado A, Gonzalez ME, Kakisu H, et al. Early physiologic changes after awake prone positioning predict clinical outcomes in patients with acute hypoxemic respiratory failure. Intensive Care Med. 2024;50(12):2105\u201313. https:\/\/doi.org\/10.1007\/s00134-024-07690-3.","journal-title":"Intensive Care Med"},{"issue":"8","key":"532_CR203","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s00134-024-07485-6","volume":"50","author":"E Antonucci","year":"2024","unstructured":"Antonucci E, Garcia B, Chen D, Matthay MA, Liu KD, Legrand M. Incidence of acute kidney injury and attributive mortality in acute respiratory distress syndrome randomized trials. Intensive Care Med. 2024;50(8):1240\u201350. https:\/\/doi.org\/10.1007\/s00134-024-07485-6.","journal-title":"Intensive Care Med"},{"issue":"11","key":"532_CR204","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s00134-024-07639-6","volume":"50","author":"A Joseph","year":"2024","unstructured":"Joseph A, Evrard B, Petit M, Goudelin M, Prat G, Slama M, et al. Fluid responsiveness in acute respiratory distress syndrome patients: a post hoc analysis of the HEMOPRED study. Intensive Care Med. 2024;50(11):1850\u201360. https:\/\/doi.org\/10.1007\/s00134-024-07639-6.","journal-title":"Intensive Care Med"},{"issue":"9","key":"532_CR205","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00134-025-08064-z","volume":"51","author":"M Brunini","year":"2025","unstructured":"Brunini M, Forel JM, Muracciole X, Roch A, Barbolosi D, Papazian L. Heterogenous treatment effect of neuromuscular blocking agents for moderate-to-severe ARDS: a post hoc Markov model re-analysis of the ACURASYS trial. Intensive Care Med. 2025;51(9):1615\u201327. https:\/\/doi.org\/10.1007\/s00134-025-08064-z.","journal-title":"Intensive Care Med"},{"issue":"5","key":"532_CR206","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1164\/rccm.202308-1376OC","volume":"209","author":"GM Plens","year":"2024","unstructured":"Plens GM, Droghi MT, Alcala GC, Pereira SM, Wawrzeniak IC, Victorino JA, et al. Expiratory Muscle Activity Counteracts Positive End-Expiratory Pressure and Is Associated with Fentanyl Dose in Patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2024;209(5):563\u201372. https:\/\/doi.org\/10.1164\/rccm.202308-1376OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"532_CR207","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1056\/NEJMoa1005372","volume":"363","author":"L Papazian","year":"2010","unstructured":"Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1005372.","journal-title":"N Engl J Med"},{"issue":"21","key":"532_CR208","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1056\/NEJMoa1901686","volume":"380","author":"L National Heart","year":"2019","unstructured":"National Heart L, Blood Institute PCTN, Moss M, Huang DT, Brower RG, Ferguson ND, et al. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med. 2019;380(21):1997\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1901686.","journal-title":"N Engl J Med"},{"issue":"6","key":"532_CR209","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1164\/rccm.202406-1231OC","volume":"211","author":"AA Zalucky","year":"2025","unstructured":"Zalucky AA, Dianti J, Neyton LPA, Sinha P, Liu KD, Matthay MA, et al. Elastance May Determine the Neuromuscular Blockade Effect on Mortality in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2025;211(6):966\u201374. https:\/\/doi.org\/10.1164\/rccm.202406-1231OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"532_CR210","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1164\/rccm.202305-0901OC","volume":"209","author":"T Charalampous","year":"2024","unstructured":"Charalampous T, Alcolea-Medina A, Snell LB, Alder C, Tan M, Williams TGS, et al. Routine Metagenomics Service for ICU Patients with Respiratory Infection. Am J Respir Crit Care Med. 2024;209(2):164\u201374. https:\/\/doi.org\/10.1164\/rccm.202305-0901OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"532_CR211","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1164\/rccm.202105-1302OC","volume":"204","author":"P Sinha","year":"2021","unstructured":"Sinha P, Furfaro D, Cummings MJ, Abrams D, Delucchi K, Maddali MV, et al. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids. Am J Respir Crit Care Med. 2021;204(11):1274\u201385. https:\/\/doi.org\/10.1164\/rccm.202105-1302OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"532_CR212","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar J, Ferrando C, Martinez D, Ambros A, Munoz T, Soler JA, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267\u201376. https:\/\/doi.org\/10.1016\/S2213-2600(19)30417-5.","journal-title":"Lancet Respir Med"},{"issue":"8","key":"532_CR213","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Group RC, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436.","journal-title":"N Engl J Med"},{"issue":"9","key":"532_CR214","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1093\/cid\/ciaa1177","volume":"72","author":"CMP Jeronimo","year":"2021","unstructured":"Jeronimo CMP, Farias MEL, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, et al. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb. Placebo-controlled Trial Clin Infect Dis. 2021;72(9):e373\u201381. https:\/\/doi.org\/10.1093\/cid\/ciaa1177.","journal-title":"Placebo-controlled Trial Clin Infect Dis"},{"issue":"13","key":"532_CR215","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2020.17021","volume":"324","author":"BM Tomazini","year":"2020","unstructured":"Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA. 2020;324(13):1307\u201316. https:\/\/doi.org\/10.1001\/jama.2020.17021.","journal-title":"JAMA"},{"issue":"13","key":"532_CR216","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2020.16761","volume":"324","author":"PF Dequin","year":"2020","unstructured":"Dequin PF, Heming N, Meziani F, Plantefeve G, Voiriot G, Badie J, et al. Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2020;324(13):1298\u2013306. https:\/\/doi.org\/10.1001\/jama.2020.16761.","journal-title":"JAMA"},{"issue":"13","key":"532_CR217","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","volume":"324","author":"DC Angus","year":"2020","unstructured":"Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, et al. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020;324(13):1317\u201329. https:\/\/doi.org\/10.1001\/jama.2020.17022.","journal-title":"JAMA"},{"issue":"5","key":"532_CR218","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","volume":"52","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena R, et al. 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia. Crit Care Med. 2024;52(5):e219\u201333. https:\/\/doi.org\/10.1097\/CCM.0000000000006172.","journal-title":"Crit Care Med"},{"issue":"21","key":"532_CR219","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"PF Dequin","year":"2023","unstructured":"Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, et al. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med. 2023;388(21):1931\u201341. https:\/\/doi.org\/10.1056\/NEJMoa2215145.","journal-title":"N Engl J Med"},{"issue":"8","key":"532_CR220","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","volume":"48","author":"GU Meduri","year":"2022","unstructured":"Meduri GU, Shih MC, Bridges L, Martin TJ, El-Solh A, Seam N, et al. Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med. 2022;48(8):1009\u201323. https:\/\/doi.org\/10.1007\/s00134-022-06684-3.","journal-title":"Intensive Care Med"},{"issue":"4","key":"532_CR221","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jama.2024.6096","volume":"332","author":"R Pirracchio","year":"2024","unstructured":"Pirracchio R, Venkatesh B, Legrand M. Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review. JAMA. 2024;332(4):318\u201328. https:\/\/doi.org\/10.1001\/jama.2024.6096.","journal-title":"JAMA"},{"key":"532_CR222","doi-asserted-by":"publisher","unstructured":"Pirracchio R, Annane D, Waschka AK, Lamontagne F, Arabi YM, Bollaert PE, et al. Patient-Level Meta-Analysis of Low-Dose Hydrocortisone in Adults with Septic Shock. NEJM Evid. 2023;2(6):EVIDoa2300034. https:\/\/doi.org\/10.1056\/EVIDoa2300034.","DOI":"10.1056\/EVIDoa2300034"},{"issue":"3","key":"532_CR223","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S2213-2600(23)00408-3","volume":"12","author":"F Gioia","year":"2024","unstructured":"Gioia F, Walti LN, Orchanian-Cheff A, Husain S. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis. Lancet Respir Med. 2024;12(3):207\u201316. https:\/\/doi.org\/10.1016\/S2213-2600(23)00408-3.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"532_CR224","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.cmi.2023.03.008","volume":"29","author":"L Ozbek","year":"2023","unstructured":"Ozbek L, Topcu U, Manay M, Esen BH, Bektas SN, Aydin S, et al. COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases. Clin Microbiol Infect. 2023;29(6):722\u201331. https:\/\/doi.org\/10.1016\/j.cmi.2023.03.008.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"532_CR225","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1007\/s00134-019-05754-3","volume":"45","author":"E Butler","year":"2019","unstructured":"Butler E, Moller MH, Cook O, Granholm A, Penketh J, Rygard SL, et al. The effect of systemic corticosteroids on the incidence of gastrointestinal bleeding in critically ill adults: a systematic review with meta-analysis. Intensive Care Med. 2019;45(11):1540\u20139. https:\/\/doi.org\/10.1007\/s00134-019-05754-3.","journal-title":"Intensive Care Med"},{"issue":"1","key":"532_CR226","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1038\/s41467-025-59643-z","volume":"16","author":"S Rajendran","year":"2025","unstructured":"Rajendran S, Xu Z, Pan W, Zang C, Siempos I, Torres L, et al. Multicenter target trial emulation to evaluate corticosteroids for sepsis stratified by predicted organ dysfunction trajectory. Nat Commun. 2025;16(1):4450. https:\/\/doi.org\/10.1038\/s41467-025-59643-z.","journal-title":"Nat Commun"},{"issue":"11","key":"532_CR227","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00134-018-5378-3","volume":"44","author":"P Sinha","year":"2018","unstructured":"Sinha P, Delucchi KL, Thompson BT, McAuley DF, Matthay MA, Calfee CS. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med. 2018;44(11):1859\u201369. https:\/\/doi.org\/10.1007\/s00134-018-5378-3.","journal-title":"Intensive Care Med"},{"key":"532_CR228","doi-asserted-by":"publisher","unstructured":"Group WHOREAfC-TW, Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, et al. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. JAMA. 2021;326(6):499\u2013518. https:\/\/doi.org\/10.1001\/jama.2021.11330.","DOI":"10.1001\/jama.2021.11330"},{"key":"532_CR229","doi-asserted-by":"publisher","unstructured":"Galvan-Roman JM, Rodriguez-Garcia SC, Roy-Vallejo E, Marcos-Jimenez A, Sanchez-Alonso S, Fernandez-Diaz C, et al. IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study. J Allergy Clin Immunol. 2021;147(1):72\u201380 e8. https:\/\/doi.org\/10.1016\/j.jaci.2020.09.018.","DOI":"10.1016\/j.jaci.2020.09.018"},{"key":"532_CR230","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00055","volume":"10","author":"E Karakike","year":"2019","unstructured":"Karakike E, Giamarellos-Bourboulis EJ. Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis. Front Immunol. 2019;10:55. https:\/\/doi.org\/10.3389\/fimmu.2019.00055.","journal-title":"Front Immunol"},{"issue":"11","key":"532_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100817","volume":"3","author":"K Leventogiannis","year":"2022","unstructured":"Leventogiannis K, Kyriazopoulou E, Antonakos N, Kotsaki A, Tsangaris I, Markopoulou D, et al. Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial. Cell Rep Med. 2022;3(11):100817. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100817.","journal-title":"Cell Rep Med"},{"issue":"18","key":"532_CR232","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","volume":"371","author":"DF McAuley","year":"2014","unstructured":"McAuley DF, Laffey JG, O\u2019Kane CM, Perkins GD, Mullan B, Trinder TJ, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med. 2014;371(18):1695\u2013703. https:\/\/doi.org\/10.1056\/NEJMoa1403285.","journal-title":"N Engl J Med"},{"issue":"3","key":"532_CR233","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/thorax-2023-220292","volume":"79","author":"P Mehta","year":"2024","unstructured":"Mehta P, Samanta RJ, Wick K, Coll RC, Mawhinney T, McAleavey PG, et al. Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS). Thorax. 2024;79(3):227\u201335. https:\/\/doi.org\/10.1136\/thorax-2023-220292.","journal-title":"Thorax"},{"key":"532_CR234","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-med-042921-112837","volume":"74","author":"RQ Cron","year":"2023","unstructured":"Cron RQ, Goyal G, Chatham WW. Cytokine Storm Syndrome. Annu Rev Med. 2023;74:321\u201337. https:\/\/doi.org\/10.1146\/annurev-med-042921-112837.","journal-title":"Annu Rev Med"},{"issue":"10","key":"532_CR235","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41591-021-01499-z","volume":"27","author":"E Kyriazopoulou","year":"2021","unstructured":"Kyriazopoulou E, Poulakou G, Milionis H, Metallidis S, Adamis G, Tsiakos K, et al. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021;27(10):1752\u201360. https:\/\/doi.org\/10.1038\/s41591-021-01499-z.","journal-title":"Nat Med"},{"issue":"6","key":"532_CR236","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","volume":"2","author":"G Cavalli","year":"2020","unstructured":"Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, et al. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020;2(6):e325\u201331. https:\/\/doi.org\/10.1016\/S2665-9913(20)30127-2.","journal-title":"Lancet Rheumatol"},{"issue":"12","key":"532_CR237","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1038\/s41591-025-03956-5","volume":"31","author":"AR Moore","year":"2025","unstructured":"Moore AR, Zheng H, Ganesan A, Hasin-Brumshtein Y, Maddali MV, Levitt JE, et al. A consensus immune dysregulation framework for sepsis and critical illnesses. Nat Med. 2025;31(12):4084\u201396. https:\/\/doi.org\/10.1038\/s41591-025-03956-5.","journal-title":"Nat Med"},{"key":"532_CR238","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.24175","author":"EJ Giamarellos-Bourboulis","year":"2025","unstructured":"Giamarellos-Bourboulis EJ, Kotsaki A, Kotsamidi I, Efthymiou A, Koutsoukou V, Ehler J, et al. Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial. JAMA. 2025. https:\/\/doi.org\/10.1001\/jama.2025.24175.","journal-title":"JAMA"},{"issue":"10","key":"532_CR239","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s40121-023-00871-5","volume":"12","author":"L Piemonti","year":"2023","unstructured":"Piemonti L, Landoni G, Voza A, Puoti M, Gentile I, Coppola N, et al. Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized. Double-Blind Placebo-Controlled Study Infect Dis Ther. 2023;12(10):2437\u201356. https:\/\/doi.org\/10.1007\/s40121-023-00871-5.","journal-title":"Double-Blind Placebo-Controlled Study Infect Dis Ther"},{"issue":"18","key":"532_CR240","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1161\/CIRCULATIONAHA.122.061533","volume":"146","author":"EA Bohula","year":"2022","unstructured":"Bohula EA, Berg DD, Lopes MS, Connors JM, Babar I, Barnett CF, et al. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT. Circulation. 2022;146(18):1344\u201356. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.061533.","journal-title":"Circulation"},{"issue":"8009","key":"532_CR241","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41586-024-07265-8","volume":"628","author":"A Gautam","year":"2024","unstructured":"Gautam A, Boyd DF, Nikhar S, Zhang T, Siokas I, Van de Velde LA, et al. Necroptosis blockade prevents lung injury in severe influenza. Nature. 2024;628(8009):835\u201343. https:\/\/doi.org\/10.1038\/s41586-024-07265-8.","journal-title":"Nature"},{"issue":"27","key":"532_CR242","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411355","volume":"12","author":"J Cui","year":"2025","unstructured":"Cui J, Yang M, Yu C, Zhang H, Gong Y, Hu Y, et al. Inhibition of RACK1-Mediated NLRP3 Oligomerization (Active Conformation) Ameliorates Acute Respiratory Distress Syndrome. Adv Sci (Weinh). 2025;12(27):e2411355. https:\/\/doi.org\/10.1002\/advs.202411355.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"532_CR243","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s43556-025-00259-6","volume":"6","author":"R Gao","year":"2025","unstructured":"Gao R, Zhang X, Ju H, Zhou Y, Yin L, Yang L, et al. Telocyte-derived exosomes promote angiogenesis and alleviate acute respiratory distress syndrome via JAK\/STAT-miR-221-E2F2 axis. Mol Biomed. 2025;6(1):21. https:\/\/doi.org\/10.1186\/s43556-025-00259-6.","journal-title":"Mol Biomed"},{"issue":"18","key":"532_CR244","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.7150\/thno.102318","volume":"14","author":"X Chen","year":"2024","unstructured":"Chen X, Shen J, Jiang X, Pan M, Chang S, Li J, et al. Characterization of dipyridamole as a novel ferroptosis inhibitor and its therapeutic potential in acute respiratory distress syndrome management. Theranostics. 2024;14(18):6947\u201368. https:\/\/doi.org\/10.7150\/thno.102318.","journal-title":"Theranostics"},{"issue":"2","key":"532_CR245","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1021\/acsnano.3c09848","volume":"18","author":"X Li","year":"2024","unstructured":"Li X, Qiao Q, Liu X, Hu Q, Yu Y, Qin X, et al. Engineered Biomimetic Nanovesicles Based on Neutrophils for Hierarchical Targeting Therapy of Acute Respiratory Distress Syndrome. ACS Nano. 2024;18(2):1658\u201377. https:\/\/doi.org\/10.1021\/acsnano.3c09848.","journal-title":"ACS Nano"},{"issue":"3","key":"532_CR246","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1164\/rccm.202209-1838ED","volume":"207","author":"CM O'Kane","year":"2023","unstructured":"O\u2019Kane CM, Matthay MA. Understanding the Role of Mesenchymal Stromal Cells in Treating COVID-19 Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2023;207(3):231\u20133. https:\/\/doi.org\/10.1164\/rccm.202209-1838ED.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"532_CR247","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1164\/rccm.202311-2046CP","volume":"209","author":"GF Curley","year":"2024","unstructured":"Curley GF, O\u2019Kane CM, McAuley DF, Matthay MA, Laffey JG. Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now? Am J Respir Crit Care Med. 2024;209(7):789\u201397. https:\/\/doi.org\/10.1164\/rccm.202311-2046CP.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"532_CR248","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-025-02313-9","volume":"10","author":"X Han","year":"2025","unstructured":"Han X, Liao R, Li X, Zhang C, Huo S, Qin L, et al. Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduct Target Ther. 2025;10(1):262. https:\/\/doi.org\/10.1038\/s41392-025-02313-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"532_CR249","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13287-023-03438-w","volume":"14","author":"B Feng","year":"2023","unstructured":"Feng B, Feng X, Yu Y, Xu H, Ye Q, Hu R, et al. Mesenchymal stem cells shift the pro-inflammatory phenotype of neutrophils to ameliorate acute lung injury. Stem Cell Res Ther. 2023;14(1):197. https:\/\/doi.org\/10.1186\/s13287-023-03438-w.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"532_CR250","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13287-023-03277-9","volume":"14","author":"K Hezam","year":"2023","unstructured":"Hezam K, Wang C, Fu E, Zhou M, Liu Y, Wang H, et al. Superior protective effects of PGE2 priming mesenchymal stem cells against LPS-induced acute lung injury (ALI) through macrophage immunomodulation. Stem Cell Res Ther. 2023;14(1):48. https:\/\/doi.org\/10.1186\/s13287-023-03277-9.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"532_CR251","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s13287-024-03977-w","volume":"15","author":"S Regmi","year":"2024","unstructured":"Regmi S, Ganguly A, Pathak S, Primavera R, Chetty S, Wang J, et al. Evaluating the therapeutic potential of different sources of mesenchymal stem cells in acute respiratory distress syndrome. Stem Cell Res Ther. 2024;15(1):385. https:\/\/doi.org\/10.1186\/s13287-024-03977-w.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"532_CR252","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13054-022-04287-4","volume":"27","author":"F Wang","year":"2023","unstructured":"Wang F, Li Y, Wang B, Li J, Peng Z. The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials. Crit Care. 2023;27(1):31. https:\/\/doi.org\/10.1186\/s13054-022-04287-4.","journal-title":"Crit Care"},{"issue":"3","key":"532_CR253","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1164\/rccm.202302-0297OC","volume":"208","author":"EA Gorman","year":"2023","unstructured":"Gorman EA, Rynne J, Gardiner HJ, Rostron AJ, Bannard-Smith J, Bentley AM, et al. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial. Am J Respir Crit Care Med. 2023;208(3):256\u201369. https:\/\/doi.org\/10.1164\/rccm.202302-0297OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"532_CR254","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.148983","author":"KD Wick","year":"2021","unstructured":"Wick KD, Leligdowicz A, Zhuo H, Ware LB, Matthay MA. Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.148983.","journal-title":"JCI Insight"},{"key":"532_CR255","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202411-2254OC","author":"MA Matthay","year":"2025","unstructured":"Matthay MA, Zhou H, Sarma A, Alipanah-Lechner N, Hendrickson C, Kornblith LZ, et al. Treatment with Allogenic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multi-Center, Phase 2b Clinical Trial (STAT). Am J Respir Crit Care Med. 2025. https:\/\/doi.org\/10.1164\/rccm.202411-2254OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"532_CR256","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1164\/rccm.202306-0969ED","volume":"208","author":"H Zhang","year":"2023","unstructured":"Zhang H, Slutsky AS. Enhancing the Efficacy of Mesenchymal Stromal Cells in COVID-19-related Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2023;208(3):222\u20134. https:\/\/doi.org\/10.1164\/rccm.202306-0969ED.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"532_CR257","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1164\/rccm.201802-0356OC","volume":"199","author":"D Islam","year":"2019","unstructured":"Islam D, Huang Y, Fanelli V, Delsedime L, Wu S, Khang J, et al. Identification and Modulation of Microenvironment Is Crucial for Effective Mesenchymal Stromal Cell Therapy in Acute Lung Injury. Am J Respir Crit Care Med. 2019;199(10):1214\u201324. https:\/\/doi.org\/10.1164\/rccm.201802-0356OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"532_CR258","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1016\/j.ymthe.2024.08.003","volume":"32","author":"C Tunstead","year":"2024","unstructured":"Tunstead C, Volkova E, Dunbar H, Hawthorne IJ, Bell A, Crowe L, et al. The ARDS microenvironment enhances MSC-induced repair via VEGF in experimental acute lung inflammation. Mol Ther. 2024;32(10):3422\u201332. https:\/\/doi.org\/10.1016\/j.ymthe.2024.08.003.","journal-title":"Mol Ther"},{"issue":"1","key":"532_CR259","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13287-020-02040-8","volume":"12","author":"T Li","year":"2021","unstructured":"Li T, Xu Y, Wang Y, Jiang Y. Differential expression profiles of long noncoding RNAs and mRNAs in human bone marrow mesenchymal stem cells after exposure to a high dosage of dexamethasone. Stem Cell Res Ther. 2021;12(1):9. https:\/\/doi.org\/10.1186\/s13287-020-02040-8.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"532_CR260","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1164\/rccm.202201-0157OC","volume":"207","author":"ME Bowdish","year":"2023","unstructured":"Bowdish ME, Barkauskas CE, Overbey JR, Gottlieb RL, Osman K, Duggal A, et al. A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19. Am J Respir Crit Care Med. 2023;207(3):261\u201370. https:\/\/doi.org\/10.1164\/rccm.202201-0157OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"532_CR261","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.537","volume":"5","author":"X Chen","year":"2014","unstructured":"Chen X, Gan Y, Li W, Su J, Zhang Y, Huang Y, et al. The interaction between mesenchymal stem cells and steroids during inflammation. Cell Death Dis. 2014;5(1):e1009. https:\/\/doi.org\/10.1038\/cddis.2013.537.","journal-title":"Cell Death Dis"},{"key":"532_CR262","doi-asserted-by":"publisher","unstructured":"Martinez-Munoz ME, Payares-Herrera C, Lipperheide I, Malo de Molina R, Salcedo I, Alonso R, et al. Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial. Bone Marrow Transplant. 2024;59(6):777\u201384. https:\/\/doi.org\/10.1038\/s41409-024-02230-5.","DOI":"10.1038\/s41409-024-02230-5"},{"issue":"1","key":"532_CR263","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13287-024-03729-w","volume":"15","author":"A Sitbon","year":"2024","unstructured":"Sitbon A, Hauw-Berlemont C, Mebarki M, Heming N, Mayaux J, Diehl JL, et al. Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life. Stem Cell Res Ther. 2024;15(1):109. https:\/\/doi.org\/10.1186\/s13287-024-03729-w.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"532_CR264","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12492","volume":"13","author":"MH Zamanian","year":"2024","unstructured":"Zamanian MH, Norooznezhad AH, Hosseinkhani Z, Hassaninia D, Mansouri F, Vaziri S, et al. Human placental mesenchymal stromal cell-derived small extracellular vesicles as a treatment for severe COVID-19: A double-blind randomized controlled clinical trial. J Extracell Vesicles. 2024;13(7):e12492. https:\/\/doi.org\/10.1002\/jev2.12492.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"532_CR265","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13287-023-03402-8","volume":"14","author":"M Zarrabi","year":"2023","unstructured":"Zarrabi M, Shahrbaf MA, Nouri M, Shekari F, Hosseini SE, Hashemian SR, et al. Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial. Stem Cell Res Ther. 2023;14(1):169. https:\/\/doi.org\/10.1186\/s13287-023-03402-8.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"532_CR266","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13287-023-03451-z","volume":"14","author":"K Ichikado","year":"2023","unstructured":"Ichikado K, Kotani T, Kondoh Y, Imanaka H, Johkoh T, Fujimoto K, et al. Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy-controlled, phase 2 multicenter study (ONE-BRIDGE). Stem Cell Res Ther. 2023;14(1):217. https:\/\/doi.org\/10.1186\/s13287-023-03451-z.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"532_CR267","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.chest.2023.06.024","volume":"164","author":"AL Lightner","year":"2023","unstructured":"Lightner AL, Sengupta V, Qian S, Ransom JT, Suzuki S, Park DJ, et al. Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19: A Randomized. Placebo-Controlled Dosing Clinical Trial Chest. 2023;164(6):1444\u201353. https:\/\/doi.org\/10.1016\/j.chest.2023.06.024.","journal-title":"Placebo-Controlled Dosing Clinical Trial Chest"},{"key":"532_CR268","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jare.2024.03.019","volume":"62","author":"PJ Chen","year":"2024","unstructured":"Chen PJ, Chen SH, Chen YL, Wang YH, Lin CY, Chen CH, et al. Ribociclib leverages phosphodiesterase 4 inhibition in the treatment of neutrophilic inflammation and acute respiratory distress syndrome. J Adv Res. 2024;62:229\u201343. https:\/\/doi.org\/10.1016\/j.jare.2024.03.019.","journal-title":"J Adv Res"},{"key":"532_CR269","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jare.2024.07.026","volume":"72","author":"SH Chen","year":"2025","unstructured":"Chen SH, Chen CH, Lin HC, Yeh SA, Hwang TL, Chen PJ. Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis. J Adv Res. 2025;72:485\u2013500. https:\/\/doi.org\/10.1016\/j.jare.2024.07.026.","journal-title":"J Adv Res"},{"key":"532_CR270","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jare.2024.01.017","volume":"67","author":"Y Ye","year":"2025","unstructured":"Ye Y, Yang Q, Wei J, Shen C, Wang H, Zhuang R, et al. RvD1 improves resident alveolar macrophage self-renewal via the ALX\/MAPK14\/S100A8\/A9 pathway in acute respiratory distress syndrome. J Adv Res. 2025;67:289\u201399. https:\/\/doi.org\/10.1016\/j.jare.2024.01.017.","journal-title":"J Adv Res"},{"issue":"17","key":"532_CR271","doi-asserted-by":"publisher","first-page":"16539","DOI":"10.1021\/acsnano.3c01814","volume":"17","author":"Q Fei","year":"2023","unstructured":"Fei Q, Shalosky EM, Barnes R, Shukla VC, Xu S, Ballinger MN, et al. Macrophage-targeted lipid nanoparticle delivery of microRNA-146a to mitigate hemorrhagic shock-induced acute respiratory distress syndrome. ACS Nano. 2023;17(17):16539\u201352. https:\/\/doi.org\/10.1021\/acsnano.3c01814.","journal-title":"ACS Nano"},{"issue":"1","key":"532_CR272","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41467-024-44905-z","volume":"15","author":"TC Hammond","year":"2024","unstructured":"Hammond TC, Purbhoo MA, Kadel S, Ritz J, Nikiforow S, Daley H, et al. A phase 1\/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome. Nat Commun. 2024;15(1):974. https:\/\/doi.org\/10.1038\/s41467-024-44905-z.","journal-title":"Nat Commun"},{"key":"532_CR273","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01150-2024","author":"S Takasawa","year":"2025","unstructured":"Takasawa S, Tateishi T, Sugihara J, Shibata S, Ito J, Ito M, et al. Emerging roles of basophils in the resolution of acute respiratory distress syndrome. Eur Respir J. 2025. https:\/\/doi.org\/10.1183\/13993003.01150-2024.","journal-title":"Eur Respir J"},{"issue":"5","key":"532_CR274","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.apsb.2025.03.023","volume":"15","author":"Z Niu","year":"2025","unstructured":"Niu Z, Xu B, Li W, Sun J, Liang H. RNA splicing: Novel star in pulmonary diseases with a treatment perspective. Acta Pharm Sin B. 2025;15(5):2301\u201322. https:\/\/doi.org\/10.1016\/j.apsb.2025.03.023.","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"532_CR275","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70344","volume":"6","author":"X Liu","year":"2025","unstructured":"Liu X, Wang H, Ni W, Dong X, Zheng M, Chang W. Global lactylome reveals lactylation-dependent mechanisms underlying CXC motif chemokine ligand 12 expression in pulmonary endothelium during acute respiratory distress syndrome. MedComm (2020). 2025;6(9):e70344. https:\/\/doi.org\/10.1002\/mco2.70344.","journal-title":"MedComm (2020)"},{"key":"532_CR276","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0086-2025","author":"Q Ma","year":"2025","unstructured":"Ma Q, Wang Y, Zhu F. Context-dependent roles of palmitoylation in acute respiratory distress syndrome: integrating inflammation, cell death and repair. Eur Respir Rev. 2025. https:\/\/doi.org\/10.1183\/16000617.0086-2025.","journal-title":"Eur Respir Rev"},{"issue":"16","key":"532_CR277","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1111\/bph.16080","volume":"180","author":"PJ Chen","year":"2023","unstructured":"Chen PJ, Tseng HH, Wang YH, Fang SY, Chen SH, Chen CH, et al. Palbociclib blocks neutrophilic phosphatidylinositol 3-kinase activity to alleviate psoriasiform dermatitis. Br J Pharmacol. 2023;180(16):2172\u201388. https:\/\/doi.org\/10.1111\/bph.16080.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"532_CR278","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13054-025-05319-5","volume":"29","author":"DB Antcliffe","year":"2025","unstructured":"Antcliffe DB, Peronnet E, Pene F, Stralin K, Brealey D, Blein S, et al. An international observational study validating gene-expression sepsis immune subgroups. Crit Care. 2025;29(1):98. https:\/\/doi.org\/10.1186\/s13054-025-05319-5.","journal-title":"Crit Care"},{"issue":"5","key":"532_CR279","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2025.101559","volume":"44","author":"L Renard Triche","year":"2025","unstructured":"Renard Triche L, Fosset M, Jabaudon M, Futier E, Lucas B, Latroche C, et al. Temporal stability of inflammatory subphenotypes of acute respiratory distress syndrome: 28-day insights from the ICAR trial. Anaesth Crit Care Pain Med. 2025;44(5):101559. https:\/\/doi.org\/10.1016\/j.accpm.2025.101559.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"6","key":"532_CR280","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S2213-2600(25)00054-2","volume":"13","author":"ES Munroe","year":"2025","unstructured":"Munroe ES, Spicer A, Castellvi-Font A, Zalucky A, Dianti J, Graham Linck E, et al. Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill. Lancet Respir Med. 2025;13(6):556\u201368. https:\/\/doi.org\/10.1016\/S2213-2600(25)00054-2.","journal-title":"Lancet Respir Med"},{"key":"532_CR281","doi-asserted-by":"publisher","unstructured":"Practical PTI, investigators RC. The rise of adaptive platform trials in critical care. Am J Respir Crit Care Med. 2024;209(5):491\u201396. https:\/\/doi.org\/10.1164\/rccm.202401-0101CP.","DOI":"10.1164\/rccm.202401-0101CP"},{"issue":"10","key":"532_CR282","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00134-016-4530-1","volume":"42","author":"ER Pfoh","year":"2016","unstructured":"Pfoh ER, Wozniak AW, Colantuoni E, Dinglas VD, Mendez-Tellez PA, Shanholtz C, et al. Physical declines occurring after hospital discharge in ARDS survivors: a 5-year longitudinal study. Intensive Care Med. 2016;42(10):1557\u201366. https:\/\/doi.org\/10.1007\/s00134-016-4530-1.","journal-title":"Intensive Care Med"},{"issue":"18","key":"532_CR283","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1001\/jama.2022.17714","volume":"328","author":"SM Fernando","year":"2022","unstructured":"Fernando SM, Scott M, Talarico R, Fan E, McIsaac DI, Sood MM, et al. Association of Extracorporeal Membrane Oxygenation With New Mental Health Diagnoses in Adult Survivors of Critical Illness. JAMA. 2022;328(18):1827\u201336. https:\/\/doi.org\/10.1001\/jama.2022.17714.","journal-title":"JAMA"},{"issue":"2","key":"532_CR284","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1164\/rccm.202206-1145OC","volume":"207","author":"J Chommeloux","year":"2023","unstructured":"Chommeloux J, Valentin S, Winiszewski H, Adda M, Pineton de Chambrun M, Moyon Q, et al. One-year mental and physical health assessment in survivors after extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome. Am J Respir Crit Care Med. 2023;207(2):150\u20139. https:\/\/doi.org\/10.1164\/rccm.202206-1145OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"532_CR285","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1164\/rccm.202110-2335OC","volume":"205","author":"CL Hodgson","year":"2022","unstructured":"Hodgson CL, Higgins AM, Bailey MJ, Mather AM, Beach L, Bellomo R, et al. Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical Illness. Am J Respir Crit Care Med. 2022;205(10):1159\u201368. https:\/\/doi.org\/10.1164\/rccm.202110-2335OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"532_CR286","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/CCM.0000000000002175","volume":"45","author":"EW Ely","year":"2017","unstructured":"Ely EW. The ABCDEF bundle: science and philosophy of how ICU liberation serves patients and families. Crit Care Med. 2017;45(2):321\u201330. https:\/\/doi.org\/10.1097\/CCM.0000000000002175.","journal-title":"Crit Care Med"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00532-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00532-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00532-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:02:07Z","timestamp":1786057327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00532-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":286,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["532"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00532-2","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"130"}}